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Abstract 
This study assessed the association between early severity of epilepsy and subsequent 
depressive symptoms in youth and the extent to which family and clinical factors 
mediated this relationship. Data were obtained from the Health-Related Quality of Life in 
Children with Epilepsy Study, a multi-centre prospective study of children with new-
onset epilepsy. A multiple linear regression analysis revealed severity of epilepsy 2 years 
post-diagnosis to be positively associated with depressive symptoms 10 years post-
diagnosis (b=2.10, 95%CI:0.42,3.79). The results of generalized estimating equation 
models found family functioning, family resources, parental depressive symptoms, and 
antiepileptic drug use to not be mediators. Five-year seizure freedom mediated this 
relationship (ab=1.22, 95%CI:0.35,2.09), decreasing the magnitude of the total effect of 
severity of epilepsy on depressive symptoms by 58%. These findings provide insight on 
long-term effects of the early clinical presentation of epilepsy. Clinical efforts to achieve 
remission may be targeted to reduce risk of depressive symptoms. 
 
Keywords: Childhood epilepsy, Depressive symptoms, Adolescents, Young adults, 
Family environment, Longitudinal study 
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Chapter 1 
1 Introduction  
This thesis examines the relationship between overall early severity of epilepsy during 
childhood as a predictor of subsequent depressive symptoms during adolescence and 
early adulthood. Moreover, it explores whether aspects of the family environment and 
proximal clinical factors play a part in the pathway of this relationship. Clarifying the role 
of familial and clinical factors on the risk of depressive symptomology will inform 
researchers and clinicians of potential targets to implement interventions. This may 
ultimately provide an opportunity to lower the risk of depression by targeting family 
factors of youth who may have had severe epilepsy during their childhood.  
This chapter will provide background information regarding epilepsy and 
introduce the burden of depression in youth who are living with epilepsy.  
 
1.1 Background  
1.1.1 Epilepsy Overview 
Epilepsy is a neurological condition characterized by a predisposition to recurrent 
epileptic seizures (1). To be diagnosed with epilepsy, a person must fit at least one of the 
following criteria: 1) two or more unprovoked seizures occurring 24 hours apart; 2) one 
unprovoked (or reflex) seizure and a probability of further seizures similar to the general 
reoccurrence risk (at least 60%) after two unprovoked seizures, occurring over the next 
10 years; or 3) diagnosis of an epilepsy syndrome (1). The International League Against 
Epilepsy’s (ILAE) classification includes three major categories of seizures: focal (motor 
or non-motor), generalized (motor or absence), or unknown onset (motor or non-motor) 
(1). Seizure type is based on the origin of seizures in the brain and are useful for 
communication purposes in clinical care and research (2,3). Generalized seizures 
originate from large areas of the cortex in both hemispheres, whereby focal seizures, 
formally referred to as partial seizures, arise from small loci of the cortex in only one 
hemisphere and may originate in subcortical structures (2). There is almost always a loss 
of consciousness associated with generalized seizures; however, in the case of focal 
seizures, impaired awareness may or may not occur (2). It is possible for patients to 
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outgrow their epilepsy, especially for those with childhood-onset mesial temporal lobe 
epilepsy who had their hippocampal sclerosis resected (1). For epilepsy to be considered 
resolved, a person must be seizure-free for at least a decade and not have taken  
antiepileptic drugs (AED) for the past five years or be past the applicable age for their 
age-dependent epilepsy (1). There is no formal definition for epilepsy being in remission, 
however experts have proposed that five years of seizure freedom and two years off 
seizure medication be used due to the modest differences in relapse rates between these 
time points and that of the criteria for epilepsy being resolved (4).  
The primary medical treatment received by the majority of people who have 
epilepsy is drug therapy in the form of antiepileptic drugs. AEDs provide good seizure 
control for 65% of patients with new-onset epilepsy (5). Over a year, AEDs completely 
eliminate seizures in 50% of new-onset patients, and reduce the frequency of seizures in 
17% of people, leaving nearly 33% of AED users with uncontrolled seizures (5). 
Approximately 30% to 40% of patients do not achieve full control over their seizures 
with a single AED, and their neurologists must experiment with different AEDs or 
combinations of AEDS to gain seizure control (5–7). Some patients experience drug-
resistant epilepsy and may be candidates for surgery. Resective surgery involves removal 
of the localized epileptogenic tissue, and has been found to control seizures in 64% to 
70% of drug-resistant temporal lobe epilepsy patients alongside AED treatment (5,8). 
Prior to attempting surgery or when surgery fails, vagus nerve stimulation is a non-
invasive palliative treatment option that has been proven to be effective for people who 
have refractory focal onset-epilepsy (9).  
 
1.1.2 Childhood-Onset Epilepsy 
There are many possible causes of childhood-onset epilepsy. It may have a genetic or 
molecular basis, occur post-infection or following an acute brain injury, or be due to 
abnormalities of cortical development, neurocutaneous disorder or hippocampal sclerosis 
(10). Although the majority of children reach remission, 13% to 17% of patients have 
refractory (intractable) epilepsy which is often associated with a poor prognosis (10). A 
large portion of patients (30%) have pharmacosensitive epilepsy for which they achieve 
good seizure control and may have a spontaneous remission after a few years. 
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Pharmacodependent epilepsy requires individuals (20%) to take their medication but they 
do not achieve remission. Lastly, people with benign epilepsies may never require 
treatment and achieve remission after a few years (10).  
Over three quarters of children with idiopathathic (no apparent cause) epilepsy, 
the most common form, are expected to be in remission by two years following diagnosis 
(11). Children who continue to have frequent seizures during the first year of treatment 
are at an increased risk of developing intractable epilepsy and never achieving one-year 
terminal remission (12). Seizure frequency is negatively correlated with epilepsy 
outcomes because it is ultimately reflective of severity of epilepsy (13). 
 
1.1.3 Prevalence of Epilepsy 
Globally, 10.5 million children up to the age of 14 are living with epilepsy, which 
constitutes 25% of all cases (14). The prevalence of childhood epilepsy ranges from 3 to 
7 per 1000 people in developed countries, as compared to 9 to 22 per 1000 people in 
developing countries (15). The higher prevalence of epilepsy in developing countries may 
be attributed to parasitic infections, a common cause of epilepsy in these countries (15).  
The incidence of epilepsy in Nova Scotia, Canada was found to decrease with age, at 118 
per 100,000 children under the age of 1, 48 per 100,000 for children between the ages of 
1 to 5 years, 43 per 100,000 for children aged 6 to 10 years, and 21 per 100,000 for 
children aged 11 to 15 (16). For children and youth up to the age of 19, the prevalence of 
epilepsy has been estimated to be 4.7 per 1000 people in Manitoba, Canada, with the 
highest prevalence in those aged 15 to 19 years (7.19 per 1000 people) and the lowest 
among children under the age of 9 (17). From two Canadian population based studies, the 
prevalence of epilepsy among adolescents aged 12 to 14 years was estimated to be 2.9 to 
4.4 per 1000 people, and for youth aged 15 to 24 years, 4.8 to 3.6 per 1000 people (18). 
The estimated median number of people with lifetime epilepsy in developed 
countries is 6.8 million of which 84% are active cases (19). In developing countries it is 
much higher at 45 million for rural areas and 17 million for urban areas of which, 
respectively, 38% and 59% are active cases (19). For people of all ages, the prevalence of 
self-reported epilepsy in Ontario has been estimated to be 5.8 per 1000 people (20). Also 
in Ontario between the years of 2004/05 and 2010/11, the prevalence of epilepsy has 
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increased from 63,898 cases to 89,867 cases (21). Among adults, the prevalence 
estimates for active epilepsy in Canada range from 5 to 10 per 1000 people (22). Reports 
from two Canadian population surveys indicate a significantly higher prevalence of 
people with self-reported epilepsy among those who have a low educational attainment 
and income and those who are unemployed (18). This is consistent with a recent study in 
the United Kingdom where epilepsy was more common in the those who had less 
education, lower income, and were less satisfied with their employment (23).  
 
1.2 Depression in Adolescents and Young Adults with Epilepsy 
Adolescence may be a difficult stage in life due to the rapid physical, social, and 
psychological development that occurs during this period (24). For youth with epilepsy, it 
may be more challenging as they try to gain independence from their parents and 
transition into being responsible for the management of their medical condition. 
Additionally, these youth continue to cope with epilepsy-related stigma and limitations 
that the disease may have placed affecting their social and physical functioning (24,25). 
The occurrence of puberty during early adolescence is a time where the frequency of 
seizures may be altered, depending on seizure type, thereby potentially changing the 
severity of their epilepsy (26). Some concerns expressed by adolescents living with 
epilepsy have been related to education/career options, potential effects of discontinuing 
AEDs, being eligible to drive, and leisure activities and alcohol use (27). A third of 
children and teenagers with epilepsy expect the disease to hinder their lives in the future, 
with the most commonly perceived problems being regarding employment opportunities 
(73%), travelling and exploring (37%), and education (36%) (28). Among teenagers 
without epilepsy, a 2001 survey of high school students found that half were not sure if 
people with epilepsy (PWE) could drive cars, work, or should have children, a third 
indicated that they would not date a person who has epilepsy, and 63% thought that youth 
with epilepsy were likely to get bullied (29). Accordingly, along with coping with the 
daily struggles of growing up with epilepsy and worrying about their future, adolescents 
may have to deal with being treated differently by their peers.  
Depression is a mood disorder that may present with a loss of energy, feelings of 
guilt, difficulty concentrating, hopelessness, or thoughts of suicide (30). The incidence of 
		
5	
depression in adolescents tends to increase with age, peaking in late adolescence/early 
adulthood (31,32). As adolescents mature into young adults there may be new pressures 
with becoming of legal age for alcohol and tobacco use, achieving higher levels of 
education, beginning occupations, or even marriage. Thus, it is not surprising that 
adolescents and young adults tend to have a higher prevalence of depression as compared 
with children (33). A study examining the temporality of mental health disorders in the 
United States found that 75% of adults with a mental health disorder had an age of onset 
before 24 years (34). In the year 2011, an estimated one million Canadian youth were 
living with a mental illness, and this is expected to increase to 1.2 million by the year 
2041 (35). 
Depression may be more problematic for youth with chronic health diseases 
such as epilepsy due to the added stress of the disease with regular life stage stressors. 
Unfortunately, many cases of mild and moderate depression among PWE go 
unrecognized and under-diagnosed by physicians due to the depressive and anxiety 
symptoms being assumed to be a reflection of the normal adaptation process to epilepsy 
(36). Symptoms of depression including decreased concentration, fatigue, and sleep 
disturbances are also mutual side effects of AEDs (37). Therefore, it is essential to 
closely monitor the mental health of youth with epilepsy. Factors predictive of 
psychopathology in PWE are multifactorial [epilepsy disease and treatment-related, 
psychosocial (including familial factors), and demographic] (38). The possible causes of 
depression include: the endocrine and/or metabolic effects of seizures, common 
pathogenic mechanisms between the two conditions, adverse effects of various AEDs, 
and or the psychological response to having epilepsy due to its mental, physical and 
social challenges (39). Depressive symptoms occurring in PWE can be categorized as 
either ictal (symptoms are a clinical manifestation of a seizure), peri-ictal (symptoms 
precede and or/occur following the seizure) and interictal (symptoms occur independent 
of the seizures) (40). Interictal depression is the most common and can present as minor 
or major depression, dysthymic disorder, or bipolar disorder (40). 
 
1.2.1 Prevalence of Depression in People with Epilepsy                                 
The Canadian Community Health Survey 2000/2001 cycle found the prevalence of 
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depression to be significantly higher (13%) among people over the age of 12 living with 
epilepsy as compared to those without epilepsy (7.2%) (41). In Alberta, the prevalence of 
depression among PWE of all ages was 28.2% based on administrative health data (42). 
For Canadians over the age of 15 years with epilepsy, the lifetime prevalence of a major 
depressive disorder was 17.4% in 2002 (43). The U.S. HealthyStyles 2004 survey 
produced results consistent with Canadian studies where adults ever diagnosed with 
epilepsy were 2.5 times more likely to self-report depression in the previous year as 
compared to people without epilepsy, after controlling for demographic factors (32.6% 
vs. 15.5%) (44). Although a larger proportion of people with active epilepsy self-reported 
depression compared to people with inactive epilepsy (39.7% vs. 23.8%), the difference 
in the likelihood of having depression between the two groups was not statistically 
significant (44). This suggests that the current state of epilepsy may not be the only 
predictor of psychiatric problems in this population, but perhaps common past or current 
biological or psychosocial mechanisms are also of importance. 
 
1.2.2 Implications of Depression for People Living with Epilepsy 
Depression is one of the most prevalent psychiatric illnesses among PWE with the 
possibility of the relationship being bidirectional (40). A few studies have found people 
with past depressive disorders to be at an increased risk of developing seizures. However, 
it may not be the case that depression causes epilepsy but rather there are common 
pathologic mechanisms responsible for the co-occurrence of these two conditions (40). 
The primary focus of research in this field is how depressive disorders develop in those 
diagnosed with epilepsy leading to negative implications on their quality of life.  
For the general public in 1998, the economic burden associated with depression 
and distress in Canada was estimated to be $278 million attributed towards direct costs 
due to psychologist and social worker visits and $6.02 billion for indirect costs due to 
missing work (45). Among children and youth, ages 10 to 24 years residing in Ontario, 
there has been a relative increase of 32.5% in mental health-related emergency 
department visits, 15.8% in office-based physician visits, and 53.7% in hospitalizations 
between 2006 and 2011 (46). Moreover, early adolescent depression has been found to 
increase the risk of having poorer self-perceived general health, increased health care 
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utilization, and increased work impairment during early adulthood while controlling for 
concurrent depression (47). Also in Ontario in 2010/11, the average costs of health 
systems use among prevalent and incident cases of epilepsy were $7283 and $10,631, 
respectively (21). The majority of these costs were attributed to hospital care, physician, 
and other health care professional services, and long-term or home care. PWE were also 
found to be four times more likely to be hospitalized for depression compared to those 
without epilepsy (48). Thus, untreated depression among PWE is likely to increase the 
use of healthcare resources with a greater need of resources for individuals with severe 
symptoms (49).  
Early detection and treatment are exceptionally important among PWE due to the 
risk of untreated depression possibly interfering with condition self-management 
behaviours, leading to poor health outcomes (50,51). Non-adherence to AEDs is more 
common among depressed epilepsy patients, and the presence of co-morbid depression 
has also been found to be associated with a lack of response to AEDs (52–54). The 
occurrence of major depression may also affect the clinical course of epilepsy, with 
patients experiencing more difficulty with the cognitive, emotional, and physical aspects 
of recovering from a seizure (55). 
Untreated depression in adolescents is associated with a high risk of self-harm and 
suicide, with more than half of suicides having a history of depression (56,57). The 
average incidence of suicide is 10-fold higher among patients with epilepsy as compared 
to the general public (40,58). In Canada, the lifetime prevalence of suicidal thoughts in 
PWE is significantly higher compared to people without epilepsy (25% vs. 13.3%) (43). 
A higher rate of death by suicide is also present among those with epilepsy (5% vs. 1.4%) 
(59). The high risk of suicide among epilepsy patients may be related to common 
mechanisms associated with the development of both major depression and epilepsy, as 
both a history of attempted suicide and major depression have been found to be 
associated with the development of unprovoked seizures (60). 
Untreated depression may also have substantial implications on the health-related 
quality of life (HRQoL) of people living with epilepsy. HRQoL, a construct referring to 
the “subjective and objective impact of dysfunction associated with an illness or injury, 
medical treatment, and health care policy”, is considered the most important health 
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outcome with respect to chronic health conditions by the ILAE Commission (61,62). 
Previous research has found patients’ HRQoL to be more strongly associated with mood 
states as compared to severity and frequency of seizures (63,64). Additionally, depressive 
symptoms have been shown to be associated with poor HRQL regardless of seizure type 
among adults (55). A strong linear relationship has been found to exist between 
depressive symptoms and HRQoL, with more symptoms being associated with lower 
HRQoL scores (64).  Among adults, depression accounts for 30% to 35% of the variance 
is HRQoL, whereby demographic and clinical factors only account for 15% to 20% (64).  																																	
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Chapter 2 	
2 Literature Review 
This chapter provides an overview of prior literature on the severity of epilepsy as a risk 
factor for depression and the importance of family environment for patients. Studies were 
located by searching the following electronic databases: PsychINFO, Pubmed 
(MEDLINE), and CINAHL. Furthermore, the ancestry method was implemented to 
identify studies that were not found in the initial searches by locating additional articles 
through reviewing the reference lists of studies.  
The first two sections review literature on the relationship between severity of 
epilepsy and other clinical factors with depression (Sections 2.1-2.2). Sections 2.3-2.5 
review literature on the association between family factors and depression in patients 
with epilepsy. The final section (Section 2.6) presents an overview of the limitations 
characterizing the literature to date. 
 
2.1 Severity of Epilepsy  
Severity of epilepsy encompasses all aspects of the disease, incorporating both clinical 
features, such as frequency and severity of seizures, and its level of disruptiveness to the 
patient’s functioning, such as falls or injuries during seizures and side effects or 
interference of drugs with daily activities (65,66). Difficulty with seizure control is likely 
to be associated with lifestyle restrictions and negative consequences on patients’ mental 
health (67,68). Thus, physicians aim to manage disease severity over time to reduce the 
risk of side effects and improve long-term outcomes through the use of treatments and/or 
by recommending interventions.  
 
2.2 Early Childhood Severity of Epilepsy and Depression 
Living with a chronic childhood illness such as epilepsy may have implications on mental 
health during adulthood. Youth and adults with childhood epilepsy experience more 
psychiatric disorders, irrespective of seizure mediation use or having gained full seizure 
control, as compared to the general public (69–71). This is not surprising given that 
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several childhood chronic conditions have been found to be associated with psychiatric 
problems and lower quality of life in adulthood (72). With regards to epilepsy, it is 
unknown whether the disease itself is the root of unfavourable adulthood outcomes, or 
whether unfavourable outcomes are due to consequences and side effects of illness, such 
as modifications in the family environment.  
The time around the diagnosis of a disease is a difficult period for both the child 
and family. Over time, once the condition becomes chronic, the long-term impact of the 
condition is perceived to be greater due to the prolonged stress (73). Following diagnosis, 
the state of a disease may change for the better, become worse, or remain stable over 
time. The effect that the disease may have on long-term psychological and physical stress 
may depend on whether the disease is quickly managed and creates minimal disruptions, 
as compared to a chronic course of illness with a greater burden (73).  
Although epilepsy is a chronic disease, the majority (65%) of children diagnosed 
gain full control of their seizures using medications within the first two years and may 
discontinue treatment (74). As a general rule of thumb for children with a promising 
prognosis, physicians recommend discontinuing AED treatment after one to two years of 
seizure freedom (74–76). The remaining children who do not gain seizure control within 
the early years following diagnosis are the ones at risk of having retractable epilepsy (77). 
Specifically, those whose seizures do not remit within two years of AED use (35%) are 
unlikely to ever be seizure free for life without an intervention (74). As such, the severity 
of epilepsy a few years after diagnosis is likely a better predictor of long-term course, as 
the disease prognosis becomes apparent by this time. 
Severity of epilepsy has not yet been tested prospectively as a risk factor for 
depression, but more severe seizures and epilepsy have been found to be associated with 
depression, emotional problems, internalizing problems, self-concept, and self-esteem 
when measured cross-sectionally (78–81). Among individual clinical factors, seizure 
frequency appears to contribute the most to ratings of severity of epilepsy (65). During 
the early stages of the disease, having frequent seizures has been found to be associated 
with depression in adolescents with varying disease durations (82,83). Thus, the 
exploration of severity of epilepsy in the early years of the disease as a risk factor for 
subsequent depression among young people with childhood-onset epilepsy seems 
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warranted. Sections 2.2.1 to 2.2.5 are a review of the clinical features of epilepsy 
(severity of seizures, frequency of seizures, AED use, seizure type, duration of epilepsy, 
and age of onset) indicative of severity of epilepsy that have been found to be associated 
with depression.  
 
2.2.1 Severity of Seizures and Poor Seizure Control 
Severity of seizures and severity of epilepsy are highly interrelated and are occasionally 
incorrectly used interchangeably. The severity of seizures is only one of several 
determinants of overall severity of epilepsy. Severe seizures may be difficult to control so 
may lower autonomy, have psychosocial implications, and decrease quality of life 
(84,85). As such, severity of seizures has been a well-studied risk factor for depression in 
people diagnosed with epilepsy (78,84,86–88). A population-based study in the UK of 
children and adolescents with epilepsy has been the only one to find increasing seizure 
severity to be independently associated with a higher risk of depression (OR= 1.09, 95% 
CI =1.01 to 1.17) (78). The mean age of epilepsy onset within this group was 6 (SD: 
4.83) years and all participants were prescribed antiepileptic medication within the last 
six months. Due to the cross-sectional nature of the study, the direction of the relationship 
between increased seizure severity and depression cannot be determined.  
Lack of seizure control is more common in those with more severe seizures and 
has been found to be associated with the risk of depression in a small number of studies. 
Among adults (n=300), effective seizure control was associated with a reduced risk of 
depression, measured using the Hospital Anxiety and Depression Scale (HADS) (89). 
Moreover, uncontrolled seizures posed a 2-fold increase in the risk of having major 
depression in 15 to 85-year-old epilepsy patients (n=298) (90). Consistent findings were 
obtained for a similar outcome of major depressive disorder (MDD) for children and 
adolescents (91). The participants (n=174) in this study had a mean onset of epilepsy of 
5.6 years and were prescribed AEDs for a minimum of 6 months prior to study 
enrollment. MDD was assessed using the Schedule for Affective Disorder and 
Schizophrenia for School Age Children: Present and Lifetime Version.  
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2.2.2 Frequency of Seizures 
Experiencing frequent seizures while using AEDs is an indicator of poor seizure control 
and worse disease severity, making it a potential risk factor for psychosocial 
consequences. A high frequency of seizures has been found to be associated with a 
number of psychiatric problems including depression, anxiety, low self-esteem, and 
stressful life experiences (92–96). Although the findings of seizure frequency being a risk 
factor for depression are mixed (87,88,97–99), a large number of studies have reported 
that the two variables are significantly related (82,83,90,91,100–106).   
 The definition used to classify frequent seizures is highly variable among studies, 
ranging from experiencing seizures on a daily basis to experiencing any seizure in the 
past week, month, or year. One study compared the frequency of seizures that people 
over the age of 16 (n=440) had in the past 2 years (none, once, more than once but not 
monthly, monthly to weekly, at least weekly) and found this to be the only epilepsy-
related risk factor for depression, measured using the Center for Epidemiological Studies 
Depression Scale (CES-D) (100). A key limitation that may explain the lack of 
associations between other epilepsy-related variables and depressive symptoms is that 
participants reflected only those who attended a primary care clinic potentially under-
representing severe cases.  
Having seizures more than once per month more than doubled the risk of 
depression in a study of adults with epilepsy (101). However, this study did not include 
all seizure types; specifically, people experiencing tonic, atonic, clonic, or atypical 
absence seizures were excluded. Adults who experienced one to three seizures monthly 
were approximately four times more likely to have depression compared to those who did 
not have a seizure every month (102). Among adolescents with childhood-onset epilepsy, 
the frequency of seizures in the preceding month was the best predictor of depressive 
disorders and also of anxiety, measured using the Diagnostic Interview for Children 
Version IV (103).  Another more recent study obtained consistent findings, however their 
outcome of interest was exclusively MDD (91). Youth with seizures occurring more than 
once a week were also more likely to have an episode of MDD compared to youth with a 
lower frequency of seizures. Furthermore, a study found that patients who had a seizure 
at least once a week were three times more likely to have depression, assessed  
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using the HADS, as compared to patients who were free of seizures for the past year 
(104).  
Seizures in the past six months were defined as frequent seizures among studies 
with exclusively adult participants. Having at least one seizure in the past six months was 
associated with a high risk of depression (RR= 1.39, 95% CI=1.12 to 1.74), assessed 
using the Hamilton Depression Scale, for women between the ages of 18 to 55 years 
(105). Additionally, a two-fold increase in the Neurological Disorders Depression 
Inventory for Epilepsy score was found among adults with epilepsy who reported at least 
one seizure in the past six months as compared to those with no seizures (90). Using the 
Patient Health Questionnaire-9 to assess depression, another study found that adults with 
seizures in the past six months with a loss of consciousness had a higher risk of 
depression (OR=5.60, 95% CI= 2.54 to 12.77) compared to those with no loss of 
consciousness (OR= 2.22, 95% CI= 1.06 to 4.66) (n=80 cases and 141 controls) (106).   
Among children and adolescents, a high frequency of seizures close to epilepsy 
onset has also been examined as a risk factor of future depression. Among children 
(n=25) with idiopathic epilepsy and a disease onset before 15.6 years, Children’s 
Depression Inventory (CDI) scores were higher in those with daily seizures than those 
who had one seizure or were seizure free after using AEDs in the early stages of the 
disease (83). Among adolescents (n=140) with an epilepsy onset between the ages of 0.3 
and 17 years, frequent seizures (weekly or daily) at the time of onset were associated with 
the risk of having depression (OR=3.52, 95% CI=1.51 to 8.17, p =0.003), assessed using 
the HADS (82). 
 
2.2.2.1 Seizure Remission 
Although epilepsy is an incurable but controllable disease, researchers sometimes classify 
patients as being in remission and or having inactive epilepsy if they have been seizure 
free for years to reduce disease-related stigma (1). There have been varying definitions of 
how many years of seizure freedom are required to be in remission with some proposing 
that it should be five years (107). Being in remission is different, however, from epilepsy 
being ‘resolved’. In the 2017 ILAE guidelines, a patient’s epilepsy is considered resolved 
if he/she had age-dependent epilepsy and are now past the applicable age or if the patient 
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has been free of seizures for the past 10 years and has not used an AED in the last 5 years 
(108).  
Although it is assumed that gaining remission would reduce the likelihood of 
epilepsy-related stigma, this is not always the case (109). A prospective study that 
followed adolescents for eight to nine years after diagnosis of childhood-onset epilepsy 
found gaining remission (five years of seizure freedom) was not associated with child-
reported health related quality of life but rather having a psychiatric illness was of greater 
importance (110). However, among this same cohort of adults, five years of seizure 
freedom was associated with a greater proportion of people reporting internalizing 
disorders (111). Among Canadian adults, experiencing even a single seizure in the past 
five years has been found to lead to a six-times greater odds of having depression as 
compared to those who achieved five-year seizure freedom (112). Failure to achieve five-
year seizure freedom was also associated with a greater risk of being unable to drive; 
experiencing limitations for education, employment, and activities of daily living; and 
having greater self-perceived stigma (112). Seizure remission has also been found to 
reduce illness intrusiveness and the severity of subjective handicap that epilepsy places 
on patients’ daily activities (113,114). One study that classified adults as being in 
remission if they had not experienced a seizure in the past year found that 4% of people 
in this group had depression as compared to 17% of people with active epilepsy. This 
trend was also apparent with anxiety where 28.9% of people with active epilepsy had 
anxiety as compared to 12.4% of people in remission (115). Alternatively, one study 
found neither seizure freedom nor any other epilepsy-related clinical factor to be 
associated with psychiatric disorders (116). Gaining seizure remission was also not found 
to effect social outcomes, but rather having a mental handicap and/or learning disorders 
were more influential (117).  
 
2.2.3 Antiepileptic Medication 
Antiepileptic drugs (AEDs) may exhibit mood-altering properties and thus, have been 
examined as risk and protective factors for mental illnesses (118). Occasionally, patients 
with less severe epilepsy do not require AEDs, others experiment with different 
combinations to gain full control of their seizures, and a select few are unsuccessful at 
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controlling their seizures with AEDs (119). Drug responsiveness has been found to 
decrease the risk of major depression among adults (OR=0.23, p<0.01), measured using 
the Diagnostic and Statistical Manual of Mental Disorders and confirmation from a 
hospital psychologist (120). Non-compliance to medication may be a problem area for 
people with depression as there is a higher occurrence of MDD in patients with poor 
medication adherence as compared to those with high or medium adherence rates (91). 
The presence of side effects of AEDs is also associated with depression, assessed using 
the HADS, among adults (n=1069) with epilepsy (92). Participants who experience 
medication side effects are approximately three times more likely to experience 
depression (AOR=3.07, 95% CI= 1.80 to 5.21) as well as anxiety (AOR=2.51, 95% CI= 
1.60 to 3.94) (104).   
The majority of studies have reported that AED type is not correlated with 
depression (97). Nonetheless, a small number of studies reported an association between 
these two factors, each with different AEDs being problematic. The AED lamotrigine has 
been found to decrease the likelihood of being depressed (OR=0.4, 95% CI= 0.2 to 0.8) 
among adults from a tertiary care centre (106). Alternatively, phenobarbital has been 
found to be associated with a higher risk of depression among children who had a family 
history of depression (121). Oxcarbazepine use, which was found to be correlated with 
frequent seizures, polytherapy treatment, and complex partial seizures has been found to 
be associated with an increased risk of depression as compared to other AEDs (OR= 2.26, 
95% CI=1.04 to 4.90) (101). This study further explored the effect of drugs by grouping 
together medications thought to have depression-inducing properties, including 
hormones, β-blockers, calcium antagonists, interferons, and some antiparkinsonian drugs, 
and found depressogenic medications to be related with a risk of depression in PWE 
(OR= 3.33, 95% CI= 1.50 to 7.39, p=0.003). 
 
2.2.3.1 Monotherapy vs. Polytherapy 
In more severe cases of epilepsy, the use of a single AED (monotherapy) is not sufficient 
to control seizures and multiple AEDs (polytherapy) are required (119). The findings on 
whether the use of more than one AED places PWE at greater risk of developing 
depression are inconclusive (122–124). Among adults who had childhood epilepsy, a 
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history of failing to achieve seizure control from two or more AEDS was not associated 
with psychiatric illnesses (111). The majority of studies, however, found monotherapy to 
be the safer treatment option with regards to the risk of psychopathology. Nonetheless, 
when seizures cannot be controlled with only one AED, polytherapy treatment is 
unavoidable. In a systematic review, four studies were identified where polytherapy was 
significantly associated with higher depression scores in children and adolescents, with 
one study finding them to be associated with the following domains of the CDI: 
interpersonal problems, ineffectiveness, and negative self-esteem (122). The findings are 
consistent in adults with one study showing almost a two-times greater risk of depression 
with polytherapy treatment (COR= 1.76, 95% CI= 1.11 to 2.78) as compared to 
montherapy treatment (90,94,102).  Another study found that a higher number of people 
had depression if they were not only using more than one AED but also using a 
clonazepam drug (88).  
2.2.4 Seizure Type 
The prognosis for epilepsy may be related to the type of epilepsy syndrome (68,125) but,  
it is difficult to determine if certain types of seizures are predictive of more severe 
epilepsy. As such, there has been plenty of research comparing types of seizures as 
predictors of depression. The majority of studies are in agreement that the laterality of 
where seizures originated and thus epilepsy type is not associated with the risk of 
depression (50,82,83,87,97,105,123). Nonetheless, there have been few studies with 
opposing results in samples spanning all ages.  A systematic review that included a total 
of 1095 children and adolescents aged 4 to 19 years with epilepsy identified four cross-
sectional studies where focal epilepsy was associated with depression to a higher degree 
than generalized epilepsy (123). Symptomatic focal epilepsies, specifically, have been 
found to be independently positively associated with depression, as measured by the Beck 
Depression Inventory (93). This study included patients aged 1 to 60 years with a mean 
age of epilepsy onset of 13.9 (SD= 9.5) years who had no history of status epilepticus for 
6 months prior to study entry. Another study (n=90) had slightly differing results, 
concluding that both generalized and focal epilepsy types are risk factors for depression 
as compared to undetermined epileptic seizures (126). Their results may have limited 
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external validity given they had a much larger proportion of undetermined seizure types 
than is found in the general population. Conversely, one study found that children (n=48) 
with generalized seizures self-reported more depressive symptoms, as measured by the 
CDI, but this finding did not hold for the parent reports of their child’s depression (127).   
Among hospitalized and/or ambulatory care patients (n=117 females and 85 
males) between the ages of 18 to 50 years with epilepsy, depression was more common in 
those with complex partial seizures and less common in those with secondary generalized 
tonic-clonic seizures (124). Tonic-clonic seizures, specifically, have been found to be 
associated with the anhedonia subscale of the CDI among children (96). Complex partial 
seizures were also found be a positive clinical risk factor for depression (OR=0.112, p 
=0.002) in patients aged 15 to 71 years (128). The number of seizure types was the 
strongest predictor of depression in their study (OR= 3.77, p =0.049). A notable study 
limitation is that their patients were from a tertiary epilepsy center, which may have led 
to an overrepresentation of severe cases. There was further support for partial seizures as 
a risk factor with another study finding that patients with partial seizures more frequently 
reported having depressive systems, identified by the Hamilton Depression Rating Scale, 
compared to patients with generalized epilepsy in their sample (n=116) with an age range 
spanning 16 to 70 years (88).  
 
2.2.5 Duration of Epilepsy and Age of Onset 
Early severity of epilepsy in some cases may predict the overall duration of disease and 
whether the child will ever outgrow it (129). Likewise, age of seizure-onset is associated 
with the type of epilepsy syndrome that may, in turn, be associated with disease 
prognosis (130,131). Although disease duration and age of epilepsy onset are not direct 
predictors of the early severity of epilepsy, they are important clinical factors to explore 
as risk factors for depression. The majority of studies are in agreement that age of 
epilepsy onset is not related to depression (50,83,86,88,91,122–124,128) but the findings 
on the relationship between duration of epilepsy and depression are inconclusive 
(91,104,122–124,128). A comprehensive review (122) identified only two studies that 
found a significant relationship between both these epilepsy-related factors and 
depression in youth (82,87). One found both age of epilepsy onset and disease duration to 
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be specifically related to the interpersonal domain score of the CDI (87). In addition to 
both being predictors of depression, a younger age of onset was also significantly 
associated with feelings of stigma among a community-based sample of adults with 
epilepsy (132). The median age of onset in this sample was 22 (range=86) years with 
43% of the sample having an onset before the age of 19.  
In addition to being a risk factor of depression, a longer duration of epilepsy is 
associated with the prevalence of MDD and anxiety in children and adolescents 
(82,83,91). Duration of disease is also associated with depression in adults with one study 
finding that having epilepsy for more than a decade increased the chances of having 
clinically significant depression symptoms (52 cases and 52 controls) (OR= 6.21, 95% 
CI= 1.66 to 23.32), assessed using the HADS (98,102). When comparing adult 
outpatients (n=116) who had mild to severe depression, those in the moderate depression 
group, identified by the Hamilton Depression Rating Scale, had the longest disease 
duration (88).  
 
2.3 The Importance of Family Environment in Childhood 
Epilepsy 
Childhood chronic diseases not only negatively impact the person with the disease but 
also their families (133). In the case of epilepsy, disease onset has been shown to bring up 
parental feelings of the ‘loss of a perfect child’ and that their child may always be 
different than other children (133,134). The progression of the illness further exacerbates 
problems by increasing feelings of frustration, hopelessness, depression, anger, and guilt 
among family members (135). Over the course of the illness, changes in family relations 
may occur due to the disease prognosis, the attached social stigma and/or the increased 
focus of parents on their child with the health condition leading to a decreased focus on 
their other children (133). As such, siblings of children with chronic epilepsy have been 
found to have higher rates of psychiatric disturbances as compared to those with newly 
diagnosed siblings (136).  
Childhood chronic illnesses increase the child’s dependency, required long-term 
care, family restrictions, and places an overall burden on the family (137). Along with 
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regular parental duties, parents have the additional responsibilities of managing their 
child’s condition and any consequences that may arise as a result, including school 
absences and lower grades. Thus, the family dynamics are forced to change to 
accommodate the needs of the illness (138). Unfortunately, these modifications in family 
processes triggered by the onset of the illness are sometimes associated with worse 
medical outcomes in the child with the condition (138). This may be due to families 
adapting poorly to the disease leading to a stressful family environment (139,140). In 
fact, the continued treatment of epilepsy has been found to increase the risk of 
maladaptive responses by both the child and his/her family (141). Consequently, families 
of children with a chronic illness are at a higher risk of developing psychological 
problems as compared to their counterparts (142).  
It is imperative that families adjust well to their child’s chronic illness as it is 
presumed to influence how the child adapts (143). Poor family adaptation is likely to 
increase the risk of poor child adjustment and in turn, the child is likely to experience 
emotional or behavioural problems (140,144). However, due to the unpredictable nature 
of epilepsy and the fears associated with seizures, there is an increased risk of parents 
becoming over-protective and emotionally over-involved with their child (87,145). 
Resources such as extended family social support, financial efficacy, and family mastery 
have all been found to aid in parental adaptation to their child’s illnesses or disability 
(140,146).  
 
2.4 The Impact of Severity of Epilepsy on the Family  
The severity of childhood epilepsy, characterized by a number of illness features such as 
frequency and severity of seizures, is likely to affect how the family reacts to the disease.  
Although no study has examined the direct impact that the overall severity of epilepsy 
has on aspects of the family environment, a number of studies have found clinical 
features of epilepsy to be related to family factors. One study found that stress within 
families was higher in those with children who experienced more frequent seizures 
compared to those with infrequent seizures or no chronic illness (147). Siblings of 
children with frequent seizures expressed more concerns about their sibling’s epilepsy as 
compared to siblings of children with infrequent seizures (147). Frequency of seizures in 
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children and adolescents has also been found to be associated with an increased risk of 
parental anxiety (148). Additionally, mothers of children with frequent seizures have 
been found to exhibit more over-controlling, anxious, and demanding attitudes (149). 
Mothers whose children with epilepsy fail to gain full control of their seizures have a 
higher risk of trait anxiety (149). A opposing study found no difference in the risk of 
parental anxiety based on the level of seizure control or seizure type (150). 
Comorbid problems such as cognitive deficits are common in people with 
epilepsy, with those who have more severe epilepsy being at higher risk (151). Children 
with epilepsy and no comorbid conditions tend to have less anxious mothers as compared 
to those with mild, moderate, or severe disabilities (150). Mothers of children with 
epilepsy who suffer from motor or ‘mental retardation’ have a higher problem-solving 
deficit, i.e. lower ability to resolve problems, compared to mothers of children with no 
epilepsy or comorbidities (149). Furthermore, a longer duration of epilepsy has been 
found to be associated with problematic family functioning and authoritarian maternal 
parenting behaviours signified by over-punishing and rigid parental attitude (149). 
Longer disease durations may be indicative of resistant and/or more severe epilepsies as 
many people with childhood epilepsy outgrow it (74).  
 
2.5 Family Factors and Youth Depression 
A family’s expectations and attitudes towards epilepsy are strong predictors of long-term 
psychological adaptation in individuals with epilepsy (137). Evidence suggests that 
family factors may have an even greater influence on child psychological adjustment to 
epilepsy than clinical factors (152). A recent study found depression in adolescents with 
epilepsy to be attributed to their negative attitudes regarding their condition and their 
family situations, rather than directly being a result of seizure or syndrome type or seizure 
intensity (153). A second study found family functioning to be the second most important 
predictor of child adjustment after pharmacological factors with other epilepsy-related 
characteristics being of lesser significance (154).  
Although the importance of family environment in childhood epilepsy is well 
known, its role as a predictor of psychopathology in children with epilepsy is now 
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increasingly being recognized and incorporated into epilepsy research (155). The findings 
of a few studies indicate that caregivers’ response to epilepsy and their relationship with 
their child may be important in lowering the risk of depression in youth who have 
epilepsy. Particularly, poor quality of the child-parent relationship and parental rejection 
have been shown to be associated with a higher risk of psychopathology in the offspring 
with epilepsy (155). Parents’ lack of confidence in managing their child’s condition and 
parental over-control are also risk factors for psychopathology and depressive symptoms, 
respectively (156,157). Furthermore, large discrepancies between a mother and father’s 
ratings of negative coping behaviours by their child with epilepsy was related to 
children’s depressive symptoms, measured using the CDI, and to poorer self-concept 
(80). This finding indicates that when two parents have different perceptions of their 
child’s coping, the child is at an increased risk of psychiatric illnesses. These differences 
in perceptions may be attributed to a number of factors including child-parent interaction 
patterns and different parenting styles within a set of parents (80). 
It is plausible that depression among primary caregivers can increase the 
likelihood of depression in their offspring. This may be attributed to a number of 
phenomena including the hereditary nature of depression, depression in parents resulting 
in negative parenting behaviours, or a shared stressful family environment resulting in 
mental health problems in all family members (158). Among adults with epilepsy (mean 
age of nearly 25 years), the most important risk factor for depression was their caregiver 
having depression (94). Other familial factors such as the caregiver’s education level, 
perception of burden and stigma, and level of family functioning were only correlated 
with depression in PWE through the meditational effects of the caregiver’s depression. 
Thus, it may be vital to diagnose and treat depression in parents early on to reduce its 
effect on the caregiver’s ability to nurture their child with epilepsy. 
Rodenburg et al. (2005) reviewed the literature on family factors as risk factors 
for psychopathology in children with epilepsy and found the contextual factors of family 
stress, family functioning, and family resources to be important predictors of child 
psychopathology, mainly depression. With the increased stress that epilepsy places on the 
family it is likely that the entire family would be affected, leading to them experiencing 
difficulties with functioning and cohesion (159). To cope with the epilepsy-associated 
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demands, adequate family resources are required as they are deemed essential for better 
psychological adjustment in children with chronic conditions (160). As both family 
functioning and resources may be more amendable to change compared to clinical 
factors, targeting them with effective family-based interventions may reduce the risk of 
psychiatric problems in youth with epilepsy (154,159). 
Although studies indicate that family factors may be associated with youth 
depression among those with epilepsy, the specific role of these factors and how they 
interact with the clinical features of epilepsy is generally unknown. It is plausible that 
family factors may play an intermediary role between clinical factors and mental health 
outcomes. Findings from past studies suggest that family reactions, behaviours, and 
circumstances may potentially mediate the physical manifestation of epilepsy and 
behavioural and emotional outcomes of family members (133). One study found that the 
effect of seizure severity on children’s depressed mood was ‘completely mediated’ by 
parent’s level of perceived stigma (161). In another study, the effect of epilepsy on 
depressed mood was rendered non-significant when controlling for family processes 
including restricted activity days, perceived life-threatening illness, and poor general 
health (157). These studies are limited by the fact that they did not test the significance of 
the indirect effect (path from exposure to outcome through the mediator). Furthermore, 
the potential mediating effects of family factors have not yet been examined, especially in 
the case of depression, representing an important target for future research.  
One review concluded that most illness-related variables were not associated with 
psychological and adaptation problems in children with less severe epilepsy and those 
with adequate seizure control (152). However, illness-related variables were important 
risk factors for psychopathology in children with severe epilepsy and those with poor 
control of their seizures. As such, the effect that epilepsy has on negative psychiatric 
problems may be based on severity of epilepsy. In agreement with other researchers, the 
authors determined that family variables, the influence of epilepsy on family life, and the 
family’s ability to cope with stress are factors that are likely to mediate the relationship 
between illness factors and psychopathology in children with epilepsy (152).  
Building on previous work and suggestions for future studies by researchers in 
this field, the current study examines family factors as mediators in the relationship 
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between severity of epilepsy and depressive symptoms. Below is a review of research on 
the three family factors selected for this study [family functioning, family resources 
(family mastery and health and extended family social support), and parental depressive 
symptoms] as potential mediators. 
 
2.5.1 Family Functioning as a Mediator 
Although epilepsy can result in psychosocial problems in the person with the disease, it 
also affects their family members and consequently their overall family system. Thus, it 
is not surprising that families with a child/adolescent who has epilepsy experience poorer 
family functioning (general functioning, affective responsiveness, affective involvement, 
behaviour control, problem solving, and communication) as compared to families of 
children without epilepsy (162). Families of children with epilepsy as compared to those 
with diabetes or no chronic illness also have poorer family cohesion and quality of 
parent-child communications (163,164). Another study had consistent findings when 
comparing children who have epilepsy with those who have another chronic disease such 
as asthma and found children with epilepsy to be less satisfied with their family 
functioning (165). However, when these same children became adolescents they were no 
more dissatisfied with their family relationships compared to adolescents with other 
chronic diseases (79). Level of maternal satisfaction with family functioning also did not 
differ between families of children with epilepsy or those with asthma (140).  
Although studies have found poorer family functioning in families with a child 
with epilepsy, whether the effect of epilepsy on family functioning varies by disease 
severity, has not been examined. Individual aspects of epilepsy that characterize higher 
disease severity have been linked to poorer family functioning, however. First, longer 
disease duration was found to be associated with poorer family functioning scores 
particularly in the areas of problem solving, communication, affective involvement, 
behaviour control, and general functioning among children and adolescents who had 
epilepsy with a disease duration ranging from 2 to 144 months (149). Among children 
with intractable epilepsy, frequency of seizures has been found to be inversely associated 
with poorer family cohesion (154). Lastly, mothers of children who had epilepsy along 
with comorbid behavioural problems reported poorer family functioning compared to 
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those whose had epilepsy alone (140). Having comorbid chronic illnesses was found to 
lower family functioning which, in turn, led to experiencing poor psychosocial 
functioning among adolescents and young adults with epilepsy (166). In this study poor 
psychosocial functioning was defined as having poor quality of life along with high 
depressive symptomology and anxiety (166). Therefore, it is plausible that family 
functioning may play a mediating role in the relationship between severity of epilepsy 
and youth psychopathology.  
A number of studies have reported a relationship between family functioning and 
depression in PWE. Children who have epilepsy and clinically significant depressive 
symptoms reported experiencing greater family conflict within the past year as compared 
to those without depression (121). However, approximately two years later, family 
conflict in this small group of children (n=28) improved, suggesting that a family’s 
response to their child’s epilepsy is not static but evolves over time (167). Mothers of 
children who had depression reported poorer family functioning compared to those whose 
child with epilepsy did not have depression (140). Among youth with childhood-onset 
epilepsy, dissatisfaction with family functioning has also been found to be associated 
with depressive symptoms (80,168). Family functioning has also been found to be 
associated with depressive symptoms in mothers of adolescents with epilepsy (94). In this 
study, family functioning was indirectly associated with adolescent internalizing and 
externalizing problems through parental depressive symptoms and the level of rejection a 
child felt towards his/her parents (94). Family functioning has also been found to partially 
mediate the relationship between parental depressive symptoms and child health related 
quality of life (169). Likewise, family functioning has been found to mediate the 
relationship between behavioural problems and emotional well-being and moderate the 
relationship between cognitive decline and self-esteem in children with epilepsy 
(170,171). 
 
2.5.2 Family Resources as a Mediator 
Families vary in the level of resources they have available to them to assist them in 
coping with stressful situations such as the care of a child with a chronic disease. Family 
resources have been found to be more problematic for families of children with epilepsy 
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compared to those with other chronic illnesses (140). For the purposes of this study, 
family resources do not refer to financial assets but rather the concepts of extended 
family social support and family mastery and health. Having sufficient social support is 
critical for families when adapting to a chronic illness and has been found to be 
associated with depression, irrespective of the level of stress in adults with epilepsy (99). 
Specifically, familial social support provided by extended family has been found to 
reduce the risk of depression in mothers of adolescents with epilepsy (172). 
Several studies have found deficits in various aspects of family resources to be 
associated with poor psychiatric health. The findings of one study indicated that families 
with fewer resources are more likely to have children with poor psychosocial adaptation 
(140). They found scores in all four subscales (esteem and communication, mastery and 
health, extended family social support, financial well-being) of the family inventory of 
resources for management (FIRM) to be significantly lower for children with depression 
or behaviour problems as compared to those without depression or behaviour problems 
(140). Austin and colleagues (1992) replicated the initial study and found poor family 
mastery and extended family social support to be associated with behaviour problems in 
children with epilepsy in a subsequent study. Moreover, level of parent-reported adaptive 
family resources were inversely associated with the depression/anxiety subscale of the 
Child Behaviour Checklist-Youth Self Report in children with epilepsy but not 
depression alone as measured by the CDI (86). Contrary to these findings, among 
adolescents with epilepsy, adaptive family resources did not differ in those with or 
without depression and or those with or without anxiety (103).  
A recent study found that improvement in neuropsychological functioning from 
seizure-onset to three years post-diagnosis was associated with reductions in symptoms 
of depression in children with epilepsy with better family mastery being a protective 
factor in this relationship (171). Consistent with this finding, two studies found the 
negative effect of parental depressive symptoms on child health-related quality of life and 
child emotional well-being, to be moderated by level of family resources (169,170). 
Although it is possible that family resources may be a moderator of the relationship 
between severity of epilepsy and patient psychopathology, it is also possible that it could 
be a mediator. A recent study found family resilience, a measure of family mastery, to 
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significantly mediate the relationship between severity of epilepsy and self-esteem in 
youth aged 13 to 16 years old (n=153) (81). Youth with more severe epilepsy reported 
poorer family resilience, and in turn, had lower self-esteem as compared to those with 
moderate-low disease severity.  
To determine the casual order of the relationship between family resources and 
patient psychopathology, a study examined whether family resources are predictive of 
internalizing problems over time (156). They assessed whether family mastery at the time 
of seizure-onset is predictive of internalizing problems, i.e. depression and anxiety, two 
years post-diagnosis (156). They found that at baseline and at the two year-follow up, 
family mastery was negatively associated with total behaviour problems, internalizing, 
and externalizing problems. Baseline family mastery was significantly negatively 
associated with increases in total, internalizing, and externalizing behaviour problems 
from baseline to two years. Thus, family mastery predicted behaviour problems over time 
with those who had higher baseline levels of family mastery showing improvement in 
child behaviour problems (156).  
 
2.5.3 Parental Depression as a Mediator 
Diagnosis of a chronic illness has been found to be associated with depression among 
caregivers (173). This may be attributed to the increased burden placed on caregivers and 
the hours they spend caring for their dependent with the burden only increasing the 
longer the time since diagnosis (173,174). Parental depressive symptoms are problematic 
for growing children as they are likely to reduce the quality of the parent-child 
relationship. Maternal depressive symptoms have been found to be positively associated 
with uncertainty regarding their child’s epilepsy and boundary ambiguity (child’s role in 
the family) and so may reduce the quality of care the child receives (175). 
 A systematic review found that mothers of children with epilepsy have high rates 
of depression with prevalence of depression ranging from 12% to 49% across six studies 
(176). A large portion (31.5%) of mothers of children with epilepsy seem to have a MDD 
(177). The prevalence of depression and anxiety in mothers of children and adolescents 
with epilepsy has been found to be significantly higher than that of mothers of healthy 
children without epilepsy (86,149). Findings are mixed, however, as other studies found 
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no difference in the risk of depression between mothers of children with epilepsy and 
mothers of children without epilepsy or another chronic disease (178,179).  
Clinical factors indicative of more severe epilepsies have been examined as risk 
factors of parental depression. The presence of ‘mental retardation’ in children with 
epilepsy, which is likely reflecting more severe epilepsy, was found to be associated with 
lower maternal educational attainment and an increased risk of maternal depressive 
symptoms (180,181). However, children having a learning disability and their fathers’ 
level of education were not associated with the risk of paternal depression (182). A longer 
duration of epilepsy was also not associated with depression in either mothers or fathers 
(181,182). Severity of epilepsy in children was found to be associated with paternal 
depression one year post-diagnosis, however, the sample was too small for the findings to 
be considered conclusive (n=11) (183). In this sample, fathers of children with 
generalized seizures appeared to have more depressive symptoms 24 months post-
diagnosis as compared to those with partial seizures (183).  
There are mixed findings on whether past or current parental depression is 
associated with depression in youth with epilepsy. A review by Otero (2009) concluded 
parent’s psychopathology to be one of the most important family factors influencing child 
psychological problems. In children with epilepsy, a family history of psychopathology 
has been shown to be a risk factor for depression (184). In a hospital outpatient sample of 
adolescents with epilepsy, parental psychopathology was found to be associated with 
depressive disorders in youth (103). Parental depression was also found to be associated 
with internalizing and externalizing behaviour problems in children and adolescents 
(155). However, two other studies did not find maternal depression to be correlated with 
children’s and adolescent’s risk of depression (86,178). In samples of people with more 
severe epilepsy, the results of all studies are consistent finding parental psychiatric 
illnesses to be predictive of psychiatric illnesses in their offspring. Among children with 
chronic or difficult to control epilepsy, a past history of maternal psychiatric treatment 
was found to be correlated with an increased risk of patient emotional and behavioural 
disturbances (141). In a previous study, Hoare (1984) also found past psychiatric illnesses 
in mothers, but not in fathers, to increase the risk of psychiatric illnesses in children with 
chronic epilepsy. 
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A number of studies have found parental depression to be associated with both the 
severity of epilepsy and youth psychiatric illness. Thus, it is plausible that parental 
depressive disorders may mediate the effect of severity of epilepsy on the risk of youth 
depressive disorders. One study found parental anxiety/depression to be significantly 
more common in parents of children who had more seizures and/or behaviour problems 
(185). More depressive symptoms in mothers of children with epilepsy were found to not 
only be associated with greater severity of illness and more child behaviour problems but 
also with maternal perceptions of greater stigma, dissatisfaction with family relationships, 
less extended family social support, and lower family income (172). Lastly, among 
children and adolescents with intractable epilepsy, behaviour problems and attention 
problems were found to be correlated with maternal depression but family income was 
not (186).  
 
2.6 Limitations of Previous Studies 
With depression being a common negative outcome in PWE, many studies have assessed 
its risk factors. However, it is also essential to establish how risk factors work together to 
create pathways in which depressive disorders may arise. This in turn will help establish 
targets for interventions to reduce the effect of less amendable clinical factors on the risk 
of depression. For example, family factors are related to psychiatric disorders in epilepsy 
patients and may be potential targets for supports but have yet to be explored as 
intermediary variables between clinical factors and depression.  
The casual relationships between risk factors and depression have not been 
explored since nearly all previous studies have been cross-sectional, measuring the 
exposure and outcome at the same time. Shortage of prospective studies has also made it 
difficult to incorporate clinical factors near onset as predictors of subsequent depression. 
Furthermore, the majority of studies have focused on assessing the individual effects of 
each clinical factor, as opposed to exploring their combined effect that forms overall 
severity of epilepsy, in turn, causing psychiatric illnesses. As no single clinical factor has 
been established to be a predictor of psychopathology in PWE, it is likely that the effect 
that epilepsy has on causing negative psychosocial outcomes is based on overall disease 
severity. Lack of examination of disease severity as a risk factor for mental illnesses may 
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have been attributed to the absence of a validated measurement tool to feasibly assess 
severity of epilepsy; this has become available in the past decade (65).  
Studies to date have employed a wide variety of samples, some of which are 
highly unrepresentative of the general population of PWE. Many studies recruit their 
participants from speciality care clinics and may have excluded milder cases of PWE. 
However, individuals with well-controlled/less severe epilepsy may still experience 
negative side effects such as the stigma that accompanies the disease and should be 
included in study samples (187). The vast majority of studies that included adults did not 
single out young adults, although the risk of depression in this age group may differ due 
to different stressors in this life stage as compared to middle and older aged adults. 
Furthermore, people who have been in remission for many years and thus have not had an 
epilepsy-related medical visit are excluded in many study samples. It is important to 
include this subgroup of people as having a chronic condition during their childhood is 
likely to have an impact on their long-term psychosocial health. There may also be 
common biological mechanisms related to epilepsy that places patients at a higher risk of 
psychiatric illnesses as compared to people who have never had epilepsy. 
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Chapter 3 
3 Study Purpose, Objectives, and Conceptual Framework  
This chapter will elaborate on the purpose of the study, state the objectives of this 
research, and provide information regarding the conceptual framework used to guide this 
project.  
 
3.1 Study Purpose 
The presence of childhood epilepsy may have long-term impacts on psychological well-
being. Nonetheless, childhood clinical predictors of long-term outcomes such as 
depression have rarely been examined. The focus of past cross-sectional and longitudinal 
studies has been to assess the effect of each factor separately, with little attention to how 
these factors may come together to predict subsequent severity of epilepsy which, in turn, 
may lead to depression. The findings of these previous studies are inconclusive (reviewed 
in Chapter 2) warranting further research, particularly regarding the association between 
overall childhood severity of epilepsy and youth mental health disorders. Thus, this thesis 
aims to determine whether severity of childhood epilepsy early in the disease course is 
predictive of later depressive symptoms in youth.  
Further, due to the multi-etiological nature of risk factors for depression and the 
established importance of family factors in childhood epilepsy (reviewed in Chapter 2), 
the role of family factors will also be investigated (133,159). Aspects of the family 
environment will be examined as potential mediating factors in the casual relationship 
between severity of epilepsy and depressive symptoms. To interpret these relationships, 
the stress process model has been selected as the conceptual framework to guide this 
research (refer to Section 3.3). Furthermore, as this is a long-term follow-up study, many 
changes may have occurred with regards to the clinical state of epilepsy. The current state 
of epilepsy is important to take into consideration as a number of cross-sectional studies 
have found epilepsy-related clinical factors that occur concurrently with depression to be 
associated with the risk of depression. Past severity of epilepsy may also be related to the 
future clinical manifestation of the disease, and thus current clinical factors will also be 
examined as mediators of the relationship between early severity of epilepsy and 
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subsequent depressive symptoms.  
An important step in epilepsy research is to elucidate pathways by which negative 
mental health outcomes manifest, and to identify factors that are amendable to change 
through interventions. The examination of family environment may present an 
opportunity to counteract or minimize the risk of depression for youth by implementing 
family-based interventions. Examining severity of epilepsy in the early course of the 
disease will inform paediatric neurologists of its potential long-term implications for 
patients. Lastly, the examination of proximal clinical factors will help determine if past 
disease severity remains important or whether its effect is greatly reduced when 
accounting for the current clinical situation.  
 
3.2 Research Objectives 
The following are the research objectives to be addressed in this thesis:  
1. To assess the association between early severity of epilepsy during childhood and 
subsequent depressive symptoms during adolescence and young adulthood, 
approximately a decade after diagnosis. 
2. To assess whether aspects of the family environment (family functioning, family 
resources, parental depressive symptoms) play a mediating role in the relationship 
between early severity of epilepsy and subsequent depressive symptoms in youth. 
3. To assess whether clinical factors (five-year seizure freedom, current AED use) play a 
mediating role in the relationship between early severity of epilepsy and subsequent 
depressive symptoms in youth. 
 
3.3 Conceptual Framework 
The stress process model was adopted as a theoretical framework to guide this research as 
presented in Figure 3.1 (188). According to the stress process model, stress occurs in two 
ways: the occurrence of discrete events and relatively chronic ongoing problems with the 
combination of both producing a synergistic effect on psychological well-being 
(188,189). In the past, social scientists have examined the impact of life events, ongoing 
life strains, coping behaviours, and social support networks and their influences on health 
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independently, although these processes all work together and should be examined as 
such (188). A key contribution of the stress process model is that it acknowledges the 
interrelationship among factors that affect mental health outcomes (188,190). It is a 
temporal framework where life stressors arise consecutively as the stress process unfolds 
to depict the causal relationship between exposure and outcome (188,189). 
The stress process model consists of primary stressors that, in turn, lead to 
secondary stressors, stress mediators, and finally the stress outcome. Various studies 
testing this framework have used depression as their outcome of interest (188,191–193). 
Specifically, one study employed the stress process model to predict depressive 
symptomology and major depression in adults with socio-demographic factors as the risk 
factors, social support as the mediator and personal resources as the moderator (192). It 
has also been used previously in epilepsy research for the health outcomes of cognitive 
functioning, emotional wellbeing, and HRQoL among children and youth (169,170,194).  
The diagnosis of epilepsy (primary stressor) and, in turn, living with epilepsy, 
where its effect is based on disease severity (secondary stressor), can lead to depressive 
symptoms (stress outcome). This relationship between severity of epilepsy and 
depressive symptoms may be mediated by a number of family factors/processes. The 
portion of the stress process model that this project aims to examine is how the secondary 
stressor (severity of epilepsy) leads to the stress outcome (depressive symptoms) via 
family mediators. The proposed stress mediators include family functioning, level of 
family resources, and parental depressive symptoms. Within the stress process model, 
mediators are coping or social support factors that produce variability in the outcome 
(188–190). Lastly, in this model, it is important to control for the background factors that 
describe the context of the stress through inclusion of the underlying characteristics of the 
subjects. The confounders in this project include: (a) demographic characteristics, such as 
child’s sex, family income, and parental living arrangements; and (b) clinical risk factors 
of the exposure and outcome, such as behavioural problems, cognitive problems, seizure 
type, and age at diagnosis.  
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 Figure 3.1: Conceptual Framework based on the Stress Process Model 
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Chapter 4 
4 Methods 
This chapter presents details of the data source used for this project, including the 
sampling methodology, data collection, and the measurement tools. In Section 3.3, the 
statistical methods used to analyze the data will be described. Finally, description of 
analyses conducted to reduce the risk of bias will be discussed including the attrition 
analysis and how missing data were handled.  
 
4.1 Data Source 
The data used for this study came from the Health-Related Quality of Life in Children 
with Epilepsy Study (HERQULES) consisting of the initial two-year follow-up study and 
the subsequent long-term follow-up study. HERQULES was a 10-year prospective study 
that employed a two-stage clustered sampling strategy to recruit children with new-onset 
epilepsy in Canada. In the first stage of sampling, all paediatric neurologists who were 
members of the Canadian Association of Child Neurology or were added to the sampling 
frame by a panel of experts were invited to participate in the study. A sample size of 72 
members resulted, of whom 53 (74%) agreed to participate. Research ethics board 
approval was obtained from the 17 relevant research ethic boards across Canada.  
The second stage of sampling consisted of the paediatric neurologists recruiting 
their eligible patients for the study based on the following inclusion criteria:  
1. New case of epilepsy seen for the first time by a participating paediatric 
neurologist within the data collection period; 
2.  Age at first diagnosis between 4 and 12 years;  
3. Parent/caregiver must have been primarily responsible for the child’s care for at 
least the past six months before completing questionnaires.  
Patients were excluded if they met any of the following criteria: 
1. Previously diagnosed with epilepsy by another physician; 
2. Diagnosed with other progressive or degenerative neurological disorder; 
3.  Diagnosed with other major non-neurological disorder that may impact their 
quality of life; 
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4. Parent/caregiver had insufficient English language skills to complete 
questionnaires.  
The parents of eligible patients who agreed to provide their address were mailed a 
letter describing the study and explaining that they would be asked to complete four 
mailed questionnaires: baseline (post-diagnosis), six months, one year, and two years 
post-diagnosis. These questionnaires sought information on their child’s HRQoL and 
their family environment, and would track changes in a number of factors over time. 
Parents were requested to provide informed consent for their child’s neurologist to 
complete forms regarding their child’s severity of epilepsy, seizure type, treatment and 
side effects at each follow-up. The parents’ self-administered questionnaires took 
approximately 45 to 60 minutes to complete and were returned by mail, whereas the 
physician forms took 5 to 7 minutes to complete and were faxed back to the HERQULES 
office (Appendix A). Of the 455 eligible parents, 373 (82%) parents were successfully 
recruited and 282 (76%) were retained at the 2-year follow-up. The Tailored Design 
Method, which involves systematic follow-ups and reminders, was used throughout the 
HERQULES project in an effort to achieve good response rates (195). 
For the subsequent long-term follow-up study, a letter of information was sent to 
invite parents and children over the age of 11 to participate to assess the current state of 
health of these youth and young adults (approximately 8 and 10 years post-diagnosis). 
Letters for the parents and their child explained that they would be required to complete 
two self-administered questionnaires, similar to the parent questionnaires in the original 
study, two years apart. The children had not previously completed questionnaires in the 
original study but were now old enough to self-report their health status. There were 220 
youth eligible to fill out the questionnaires available as either web-based or paper 
questionnaires to increase participation rates (196). Research ethics approval was only 
required from the Western University Health Science Research Ethics Board for the long-
term follow-up, given the established relationship with families from the initial phase of 
this project (Appendix D). Informed consent to contact and obtain information about the 
PWE’s condition from their epilepsy care physician, if still receiving care, was obtained 
from the parents if the PWE was under the age of 16, both the parent and PWE if between 
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the ages of 16 and 18 and only the PWE if 18 years or older. Physicians, parents, and 
youth all received a token of appreciation for participating.  
 
4.2 Measurement 
Below is a description of how the exposure, outcome, mediators, and confounders were 
measured, categorized by respondent type (physician, parent, youth). 
 
4.2.1 Physician Report  
Severity of Epilepsy 
The overall severity of epilepsy was measured using the Global Assessment of Severity 
of Epilepsy (GASE) Scale (65). This single item tool is designed for neurologists to rate 
their patient’s overall severity of epilepsy. The question asked is “Taking into account all 
aspects of this patient’s epilepsy, how would you rate its severity at his/her last visit? 
Please check one answer”. The options are as follows: (7) extremely severe, (6) very 
severe, (5) quite severe, (4) moderately severe, (3) somewhat severe, (2) a little severe, 
(1) not at all severe. The GASE has been found to have adequate construct validity, 
stability and responsiveness to clinical changes as well as good intra and inter-rater 
reliability (65,66).  
Seizure Type  
Physicians reported the epilepsy syndrome and types of seizures that the patient had 
according to the ILAE’s classifications (primary generalized, absence, simple/complex 
partial, BECRS, secondarily generalized, BECRS + secondarily generalized and 
undetermined) (197,198). These two variables, seizure type and epilepsy syndrome, were 
used to compute a summary variable grouping the seizures broadly into generalized, 
partial or undetermined.  
Behavioural Problems 
Physicians reported whether patients had behavioural problems, rated the severity (mild, 
moderate, severe) and reported on diagnosed behavioural problems.  
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Cognitive Problems 
Physicians reported whether patients had cognitive problems, rated the severity (mild, 
moderate, severe) and reported on diagnosed cognitive problems.  
Age at Diagnosis 
The age at the time of epilepsy diagnosis was determined based on the child’s date of 
birth and the date of their first visit in which they were diagnosed by their paediatric 
neurologist participating in the HERQULES study.  
 
4.2.2 Youth Report 
Depressive Symptoms 
Youth depressive symptoms were measured using the Center for Epidemiological Studies 
Depression Scale (CES-D)(199). The adult version was used as opposed to the child 
version, as it was age appropriate for the majority of youth and would allow for a 
consistent measure for the entire sample and across follow-ups (Appendix B). This is a 
20-item scale that is designed to measure depressive symptoms in the general adult 
population over the past week. Respondents are asked to rate on a four-point Likert scale 
the number of days they felt a certain way ranging from 0 (rarely or none of the time/less 
than one day) to 3 (most or all of the time/5-7 days). The total scores range from 0 to 60 
with a score of 16 or higher indicating that the person may be at risk of having a 
depressive disorder. The CES-D has been found to have high internal consistency, 
concurrent validity and construct validity in the general population (199). The CES-D had 
adequate internal consistency in our sample of youth with a Cronbach’s alpha of 0.69.  
Seizure Freedom 
At the 10-year follow-up, youth were asked “When was your last seizure? (It is OK to 
provide your best guess)”. The options were: less than 6 months ago, 6 months ago to less 
than 1 year ago, 1 year ago to less than 2 years ago, 2 years ago to less than 5 years ago, 5 
years to less than 10 years ago, 10 years ago or more, I don’t remember. In the event that 
youth did not report or did not recall how long ago their last seizure was, the value 
reported by their primary caregiver was imputed. This variable was dichotomized into 
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five years of seizure freedom being achieved or not achieved to handle the unequal size 
between intervals and to be comparable with past studies.  
AED Use 
At the 10-year follow-up, youth were asked “Are you currently taking any medication(s) 
to treat epilepsy or seizures?” and they responded with either “yes” or “no”. 
 
4.2.3 Parent Report 
Sex 
The child’s sex was reported by their primary caregiver. They were asked “Is your child:” 
and were provided with two options: “Male” or “Female”.  
Family Income 
Primary caregivers were asked “In which category is your total yearly household income 
before taxes?”. At the 10-year follow-up, the income categories included: less than 
$20,000, $20,000 to $29,999, $30,000 to $39,999, $40,000 to $49,999, $50,000 to 
$59,999, $60,000 to $69,999, $70,000 to $79,999, $80,000 to $89,999, $90,000 to 
$99,999, $100,000 to $149,999, greater than $150,000. These income categories were 
collapsed into four categories of equal size: less than $50,000, $50,000 to $100,000, 
$100,000 to $149,999, greater than $150,000 due to a low cell count in half the categories 
and for ease of interpretation.  
Parental Living Arrangements 
Primary caregivers were asked “Are you currently living with a spouse or partner” with 
the two options provide being “yes” or “no”.  
Family Functioning 
Family functioning was measured using the Family Adaptability, Partnership, Growth, 
Affection and Resolve (APGAR)(200). This is a 5-item scale measuring perception of 
family functioning by examining satisfaction with family relationships in the five 
dimensions: Family Adaptability, Partnership, Growth, Affection and Resolve (Appendix 
C). For each dimension, respondents are to rate the frequency of satisfaction with family 
functioning on a three-point Likert scale ranging from 0 (hardly ever) to 2 (almost 
always). The scores range from 0 to 10 with a higher score indicating more satisfaction 
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with family functioning. In clinical and research settings, the Family APGAR has been 
found to be both valid and reliable (200–202). The APGAR had high internal consistency 
in our sample with a Cronbach’s alpha of 0.88. 
Family Resources 
The extent to which families had resources available to help them adapt to stressful life 
events was measured using the Family Inventory of Resources for Management (FIRM) 
(203) (Appendix C). The two subscales included were Family Mastery and Health (20 
items) and Extended Family Social Support (4 items) as they have been found to be 
associated with adaptation to childhood epilepsy (204). Respondents rate how each 
statement describes their family situation on a four-point Likert scale ranging from 0 (not 
at all) to 3 (very well). The FIRM has demonstrated adequate reliability and validity 
(203). The FIRM had adequate internal consistency in our sample with a Cronbach’s 
alpha of 0.91 for the family mastery and health subscale and 0.64 for the extended family 
social support subscale.  
Parental Depressive Symptoms 
Parental depressive symptoms were measured using the same measure completed by the 
participating youth, the Center for Epidemiological Studies Depression Scale (CES-D) 
(199), described in Section 3.2.2 (Appendix C). The CES-D had adequate internal 
consistency in our sample of parents with a Cronbach’s alpha of 0.74. 
 
4.3 Statistical Analysis 
All analyses were conducted using SAS software version 9.2 for Windows  
(SAS Institute Inc., Cary, NC, USA). Below is a description of the analyses conducted: 
descriptive, multiple linear regression, mediation and attrition analysis. 
 
4.3.1 Descriptive Analysis 
Clinical, familial, and demographic characteristics of the sample were described using 
frequencies and proportions for categorical variables, and means and standard deviations 
for continuous variables at each of the data collection points (baseline, 6 months, 1 year, 
2 years, 8 years, 10 years). Bivariate regression analyses were conducted to assess which 
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factors were associated with the outcome without controlling for other factors. The 
following relationships were examined: the outcome (youth depressive symptoms) and 
the exposure (severity of epilepsy), the outcome and the mediators (family functioning, 
family resources, parental depressive symptoms, five-year seizure freedom, AED use), 
and the outcome and potential confounders (sex, age at diagnosis, seizure type, 
behavioural problems, cognitive problems, parental living arrangements, family income).  
 
4.3.2 Multiple Linear Regression Analysis 
A multiple linear regression analysis was conducted with youth depressive symptoms as 
the outcome to examine its relationship with the exposure (severity of epilepsy) while 
controlling for a number of clinical and demographic confounders. Potential confounders 
were sex, age at diagnosis, seizure type, behavioural problems, cognitive problems, 
parental living arrangements, and family income. The confounders were selected based 
on those factors that have been found to be predictors of depression in PWE and are 
likely to be associated with severity of epilepsy (41,78,82,87,88,93,97,123,126,132,205–
208).  
The outcome of interest, youth depressive symptoms, was measured at the 10-
year follow-up. The exposure of interest, severity of epilepsy, was measured at the 2-year 
follow-up to allow physicians sufficient time to characterize the seizure type and try to 
arrive at whether an effective combination of drugs could be found to control seizures 
(74,77). The clinical confounders (seizure type, age at diagnosis, behavioural problems, 
cognitive problems) were measured at the 2-year follow-up, as they are highly associated 
with the exposure of interest. The demographic confounders (parental living 
arrangements, family income) were measured at the 10-year follow-up as they are likely 
to be more predictive of the outcome, depressive symptoms at 10 years, as compared to 
demographic characteristics around diagnosis. Additionally, these time points were 
selected to reduce the risk of intermediate confounding that may introduce bias when 
conducting the mediation analysis. Intermediate confounding may occur when the 
exposure is a causal risk factor of a mediator-outcome confounder (209,210).  Lastly, the 
assumptions for linear regression (linearity, normality of residuals, lack of 
multicollinearity, autocorrelation, heteroscedasticity) were all met. 
		
41	
4.3.3 Mediation Analysis 
Often in psychosocial research it is the case that a risk factor does not directly cause an 
outcome but it arises through a third or intermediary variable. This third variable is 
termed a ‘mediator’ and is a carrier of information along a casual chain (211). Figure 4.1 
depicts the possible pathways between an exposure and outcome with and without the 
presence of a mediator (212,213). The total effect (c=ab + c’) is the effect of the exposure 
on the outcome without taking the mediator into account. The direct effect is the effect of 
the exposure while controlling for the mediator (c’=c-ab) as if it were a confounder. 
Lastly, the path from the exposure to the outcome through the mediator is termed the 
indirect effect (ab) and is calculated from subtracting the total effect from the direct effect 
(c-c’).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
c 
c’ 
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Figure 4.1: Mediation pathway 
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In this thesis, both family (family functioning, family resources, parental 
depressive symptoms) and clinical (five-year seizure freedom, AED use) factors were 
assessed as mediators in the relationship of severity of epilepsy and depressive 
symptoms. An important assumption of mediation is that the exposure is a predictor of 
the mediator and that the mediator is a predictor of the outcome (214). Thus, the family 
factors as potential mediators were measured at the 8-year follow-up to allow a temporal 
order between exposure, mediators, and outcome, a practice that is optimal when 
assessing casual relationships (215). Additionally, preliminary cross-lagged panel 
analyses and regression analyses were conducted to determine the casual order between 
severity of epilepsy and the selected family mediators (Appendix E). A cross-lagged 
panel analysis is used to determine the direction of the relationship between two variables 
measured at multiple time points in a longitudinal study. This is done by examining 
whether variable X at Time 1 and variable Y at Time 2 are associated or variable Y at 
Time 1 and variable X at Time 2 are associated (216). The results of these analyses found 
that severity of epilepsy was predictive of each of the family mediators (family 
functioning, family resources, parental depressive symptoms) and that these relationships 
were likely not bidirectional. The clinical mediators were measured at the 10-year follow-
up due to the nature of these variables as they are more likely to be predictive of 
depressive symptoms and not vice versa. It is unlikely that depressive symptoms in the 
past week could cause five years of seizure freedom being achieved and/or AEDs being 
prescribed. 
A rigorous method using generalized estimating equations (GEE) proposed by 
Schlucter (2008) was used to test mediation, i.e. the significance of the indirect effect. 
This method is based on the counterfactual framework where the influence of the 
mediator on the exposure and outcome relationship is assessed by observing the same 
individual at the same point in time with the mediator present or it absent. Thus, to apply 
this method, the data set must be duplicated as depicted in Table 4.1.  
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Table 4.1: Duplicated data set in preparation for GEE mediation analysis 
ID Y X G M* 
1 y1 x1 1 0 
1 y1 x1 0 m1 
2 y2 x2 1 0 
2 y2 x2 0 m2 
n yn xn 1 0 
n yn xn 0 mn 
 
The first set where the indicator variable (G) is equal to 1, the mediator (M*) is not 
present and thus is not adjusted for when examining the association between the exposure 
(X) and outcome (Y). This set may be fit to the following model:  
E(Y) = β0 + β1X1 + θ0 + θX 
= (β0 + θ0) + (β1 + θ)X  
In the second set, G=0 and thus the mediator is present and being controlled for in the 
assessment of the relationship between X and Y. This set can be fit to the following 
model:  
E(Y)= β0 + β1X1 + γM 
The overall dataset created includes two copies per individual differing on whether the 
mediator is controlled for or not and is then fitted to:  
E(Y)= β0 + β1X1 + θG + θGX +γM*  
This model computes the difference between the coefficients from the full model 
(adjusted for the mediator) and the reduced model (unadjusted for the mediator), i.e. the 
indirect effect (θ). This is done in SAS software using the PROC GENMOD function 
which also computes the significance of the indirect effect using a robust “sandwich” 
estimator for the computation of the standard error. The validity of the GEE approach for 
different combinations of binary and continuous outcomes and mediators has been 
verified in a simulation study (217).  
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4.3.4 Attrition Analysis 
An attrition analysis was conducted to determine whether the group of participants 
retained by the 10-year follow-up and those who did not participate in the 10-year follow-
up differ in terms of any clinical, family, or demographic factors. The two groups of 
participants were compared on baseline clinical (severity of epilepsy, seizure type, 
cognitive problems, behavioural problems, age at diagnosis), demographic (sex, parental 
living arrangements, family income), and family factors (parental depressive symptoms, 
family resources, family functioning) using t-tests to compare means for continuous 
variables and chi-square tests and/or fisher’s exact test to compare proportions for binary 
variables.  
 
4.3.5 Missing Data 
For a small number of patients where severity of epilepsy, seizure type, presence of 
cognitive problems or, presence of behaviour problems was missing due to physicians not 
having an opportunity to evaluate at the two-year follow-up, previously reported values 
for these variables were imputed where possible. For severity of epilepsy and seizure 
type, members of the research team reviewed all available study data, including when the 
youth’s most recent seizure was; when AEDS were discontinued; communication 
between the study coordinator and the primary caregivers of children with epilepsy at the 
two-year follow-up; the type and etiology of seizures; and the trends in past and 
subsequent severity of epilepsy and seizure types. Imputations were not made where there 
was uncertainty regarding the risk of the previously reported type of seizures and severity 
of epilepsy changing. For cognitive and behaviour problems, all available study data 
including past history, trends and taking into consideration future reports on cognitive or 
behaviour problems was used. These future reports included both follow-ups with their 
physicians and parents reporting if their child ever had any cognitive (developmental 
delay, learning disability) or behaviour problems (conduct disorder, oppositional defiant 
disorder, attention deficit disorder and/or attention deficit hyperactivity disorder) at the 
10-year follow-up. Imputations were not made where there was uncertainty regarding the 
presence of these comorbidities at the two-year follow-up. 
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Approximately 82% of the sample had no missing values for any of the variables 
after imputations using previous follow-up data was implemented. Nevertheless, 
conducting a full case analysis would result in loss of nearly 18% of the sample 
potentially leading to the group of participants analyzed being unrepresentative of the 
sample. The vast majority of missing values were attributed to the mediators and 
demographic confounders as these variables were from the most proximal follow-ups. 
The second imputation method selected to deal with the high proportion of missing 
values was multiple imputation using the fully conditional method. Multiple imputation is 
a superior technique to deal with missing data as it accounts for the uncertainty of 
missing-data prediction (218). It consists of three phases. First, missing values are filled 
in numerous times creating multiple data sets; 20 imputations were done in this project to 
match the proportion of missing cases. These data sets are then analyzed separately and 
lastly, the estimates are pooled taking into account the uncertainty due to having missing 
data (218). The fully conditional method was used as it allows a different distribution for 
each imputed variable; logistic regression was used for binary variables and the 
predictive mean matching method was used for continuous variables (219). The 
predictive mean matching method was selected over regression as it imputes random 
values that are consistent with those observed in the dataset (219). All variables used in 
the analyses models were used in the multiple imputation model (220). A sensitivity 
analysis was run using list wise deletion for participants with any missing data to show 
that the results of the imputed dataset were consistent with those from the complete-case 
analysis (Appendix F).  
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Chapter 5 
5 Results 
The study findings are presented in this chapter beginning with a description of the 
sample and their families. Next, the results of the attrition and bivariate analyses are 
presented (Sections 5.2-5.3). The last three sections (5.4-5.6) present the results of each 
research objective. 
 
5.1 Sample Characteristics  
Characteristics of the youth that remained consistent over time (age at diagnosis, sex) and 
youth self-report measures collected only at 10 years are shown in Table 5.1. Of the 131 
youth who participated in the 10-year follow-up, 3 did not report on the outcome of 
interest (depressive symptoms) and were excluded from the study. Of these youth, 37.2% 
had depressive symptoms that were clinically significant (CES-D>16) with a group 
average CES-D score of 12.6 (SD: 10.2). The youth in our sample ranged in age from 12 
to 23 years with the average age being 17.8 (SD: 2.6) years at the 10-year follow-up. 
These children were diagnosed with epilepsy between the ages of 3 and 12 years, with the 
group average being 7.5 (SD: 2.5) years. There was a similar proportion of males (48.8%) 
as there were females (51.2%). At the 10-year follow-up, the majority of youth were 
living with family (84%) and only 8% were living with a roommate or partner. Almost all 
the adolescents, except for 2%, were still in school. Of the young adults, 16% were not in 
school at the 10-year follow-up due to taking a year off, already having completed their 
post-secondary education, or not planning to continue their educational journey past high 
school.  
Over half (59.7%) the youth had been free of seizures for at least the past five 
years and very few (11.6%) had experienced a seizure within the past year. Similarly, the 
majority of the sample were not currently using AEDs (72.1%), with most having 
discontinued use two or more years ago (65.8%). A small proportion of the youth had 
never required AEDs to control their seizures (11.8%). The majority of youth were no 
longer receiving care for their epilepsy (65%) and of those still receiving care, 4% were 
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receiving epilepsy care from a family doctor, 13% from an adult neurologist, and 8% 
from a paediatric neurologist. 
Characteristics of the families of youth with epilepsy measured at all six data 
collection points are shown in Table 5.2. The annual family income increased for 53% of 
families, remained similar for 34%, and decreased for 14% from baseline to the 10-year 
follow-up. At the 10-year follow-up, nearly half the sample had an annual household 
income of $100,000 or greater, and very few had an annual household income of less than 
$40,000 (11.7%). Nearly all of the primary caregivers who participated were the 
children’s biological mothers. At the 10-year follow-up, majority of primary caregivers 
were working either full or part-time (71%), 9% were not working, 12% were 
homemakers, and 1% were students. Most primary caregivers had completed some form 
of post-secondary education (81%), 10% had completed high school and 1% did not. 
Also at the 10-year follow-up, the majority of primary caregivers were living with a 
partner (79.1%) with 76% currently married (with 3% of those re-married), 13% 
divorced, separated or widowed, and 3% never married. Overall, families were 
functioning well and had an adequate amount of resources and this remained stable over 
the 10-year period following the child’s diagnosis of epilepsy. The average score on the 
CES-D among primary caregivers was highest at the time of diagnosis, but on average 
remained stable over time. The prevalence of primary caregivers who had clinically 
significant depressive symptoms did not fluctuate much over time, ranging from 23% to 
28% across time points.  
Characteristics of the youth at each of the six data collection points are shown in 
Table 5.3. In our sample (n=129) the average severity of epilepsy improved from 
somewhat severe at the time of diagnosis to a little severe by the six-month follow-up. 
Following the six-month follow-up, on average, the severity of epilepsy remained stable. 
From diagnosis to the 2-year follow-up, the severity of epilepsy for about a quarter of the 
patients remained the same (28%), for approximately half it became less severe (57%), 
and for 15% it became more severe. The types of seizures children were experiencing 
were the same as those with which they were initially diagnosed at the 2-year follow-up 
for almost all the patients (95%). At the 2-year follow-up, 35.7% of children had 
generalized seizures and 51.2% had partial seizures. The number of children with 
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cognitive problems nearly tripled from the time of diagnosis to the two-year follow-up, 
while the increase in the number of children with behavioural problems was minimal. At 
the 2-year follow-up, 19.4% of children had cognitive problems and 13.2% had 
behavioural problems.  
 
5.2 Attrition Analysis 
A flow chart presenting the number of parents and youth retained at each data collection 
point can be found in Figures 5.1 and 5.2. A sample of 373 parents of children with 
newly diagnosed epilepsy were recruited to participate in the study. For the long-term 
follow-up study at 8 and 10 years post-diagnosis, youth self-report was added. At the 10-
year follow-up, 131 (60%) youth self-reported on their health. The results of the attrition 
analysis comparing youth who participated in the 10-year follow-up of the study with 
those who did not are presented in Table 5.4. These two groups of youth did not differ in 
terms of their sex, the age that they were diagnosed with epilepsy, the severity of their 
epilepsy, or their seizure type. However, those who did not participate in the 10-year 
follow-up were less likely to have been diagnosed with comorbid cognitive (27% vs. 7%) 
or behavioural problems (18% vs. 9%) at the time of epilepsy diagnosis. Non-
participators were also from families of lower income and fewer family resources, and 
their primary caregivers were more likely to have depressive symptoms compared to 
those who participated at the 10-year follow-up. There was no difference between 
participants and non-participants for the level of family functioning and whether the 
primary caregiver was living with their partner.  
 
 
 
 
 
 
 
 
		
49	
 
 
 
 
 
 
 
 
 
 
 
 
                    
 
                   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1: HERQULES flow chart of parent sample  
 
QUESTIONNAIRES 
RETURNED 
QUESTIONNAIRES 
SENT 
Patients Identified (n= 496) Excluded (n=41) 
Eligible (n=455)  
10 Years (n=173) 10 Years (n=215) 
Lost to follow-up = 30 
Unable to contact = 8 
Became Ineligible = 2	
Parent withdraw = 2 	
         Baseline (n= 442) Baseline (n=373) 
6 months (n=373) 6 months (n=334) 
1 Year (n=334) 1 Year (n=301) 
2 Years (n=301) 2 Years (n=282) 
Lost to follow-up = 29 
Became ineligible = 2 
Parent withdraw = 2 
 
Lost to follow-up = 34 
Became ineligible = 4 
Parent withdraw = 1 
 
Lost to follow-up = 62 
Parent withdraw = 7 	
Lost to follow-up = 17 
Parent withdraw = 2 	
8 Years (n=216) 8 Years (n=192) Lost to follow-up = 23 PI withdraw = 1 
Excluded 66: 39 unable to 
locate, 17 declined, 8 
province withheld, 2 became 
ineligible 
Declined (n=8) 
Unable to contact (n=5) 
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Figure 5.2: HERQULES flow chart of youth sample  
 
5.3 Bivariate Analysis 
The results of the bivariate analysis (Table 5.5) suggest that early severity of epilepsy was 
significantly associated with later depressive symptoms (β= 2.25, 95% CI: 0.63, 3.88). Of 
the potential confounders, only age at diagnosis was significantly associated with 
subsequent youth depressive symptoms (β= 0.95, 95% CI: 0.22, 1.68). Of the potential 
mediators, family functioning (β= -0.60, 95% CI: -1.08, -0.11), family resources (β= -
0.20, 95% CI: -0.36, -0.04), five-year seizure freedom (β= 7.65, 95% CI: 4.16, 11.14), 
and AED use (β= -5.56, 95% CI: -9.55, -1.56) were all significant predictors of youth 
depressive symptoms. The only potential mediator of the relationship between early 
severity of epilepsy and subsequent youth depressive symptoms that was not significantly 
associated with the outcome was parental depressive symptoms (β= 0.06, 95% CI: -0.13, 
0.25).  
 
 
Declined (n=36) 
Unable to contact (n=8) Eligible (n=220)  
8 Years (n=154) 8 Years (n=176) 
Lost to follow-up = 21 
Youth withdrew = 1 	
10 Years (n=131) 10 Years (n=176) 
Lost to follow-up = 40 
Unable to contact = 7 
Became eligible = 3 
Youth withdrew = 1 
 
QUESTIONNAIRES 
SENT 
QUESTIONNAIRES 
RETURNED 
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5.4 Objective 1 
To determine whether early severity of epilepsy was an independent risk factor for 
depressive symptoms among youth with epilepsy, a multiple linear regression analysis 
was conducted adjusting for potential confounders. Severity of epilepsy was measured at 
the 2-year follow-up and depressive symptoms were measured at the 10-year follow-up. 
The following clinical and demographic factors were controlled for as potential 
confounders: seizure type, cognitive problems, behavioural problems, age at diagnosis, 
sex, family income, and parental living arrangements. The results (Table 5.6) suggest that 
early severity of epilepsy was significantly associated with depressive symptoms, 
adjusting for potential confounders, with a parameter estimate of 2.10 (95% CI: 0.42, 
3.79 for a 1-unit increase on the GASE scale assessing severity of epilepsy. Thus, the 
more severe the childhood epilepsy youth had, the more likely they were to have later 
depressive symptoms.  
 
5.5 Objective 2 
5.5.1 Family Functioning 
A generalized estimating equations (GEE) model was used to assess the potential 
mediating effect of family functioning around eight years post-diagnosis on the 
relationship between early severity of epilepsy and subsequent youth depressive 
symptoms, adjusting for potential confounders. The potential confounders were the same 
clinical (seizure type, cognitive problems, behavioural problems, age at diagnosis) and 
demographic (sex, family income, parental living arrangements) factors that were 
controlled for in the analysis to address the first objective. The GEE model computed 
both the direct effect of severity of epilepsy on depressive symptoms, while adjusting for 
family functioning (M*) and the indirect effect of this relationship (G*severity of 
epilepsy) (Table 5.7). The total effect of severity of epilepsy assessed in the first 
objective was 2.10 (95% CI: 0.42, 3.79). Once the potential mediating effects of family 
functioning were adjusted for, the estimate of the direct effect decreased to 1.86 (95% CI: 
0.10, 3.61). The magnitude of the indirect effect (i.e. the difference between the presence 
of the potential mediator in the model or not) was 0.25, which indicates that family 
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functioning reduced the effect that severity of epilepsy had on the risk of depressive 
symptoms by nearly 12%. However, when testing the significance of the indirect effect, 
the GEE model indicated that family functioning did not mediate the relationship 
between early severity of epilepsy and subsequent youth depressive symptoms (ab= 0.25, 
SE: 0.17, 95% CI: -0.08, 0.57). 
 
5.5.2 Family Resources 
The potential mediating effect of family resources around eight years post-diagnosis on 
the relationship between early severity of epilepsy and subsequent youth depressive 
symptoms, adjusting for potential confounders, was assessed (Table 5.8). The total effect 
of severity of epilepsy assessed in the first objective was 2.10 (95% CI: 0.42, 3.79 and the 
estimate of the direct effect when adding family resources (M*) into the model decreased 
to 1.88 (95% CI: 0.13, 3.63). The magnitude of the indirect effect was 0.22, which 
indicates that family resources reduced the effect that severity of epilepsy had on the risk 
of depressive symptoms by 10%. However, when testing the significance of the indirect 
effect, the GEE model indicated that family resources did not mediate the relationship 
between early severity of epilepsy and subsequent youth depressive symptoms (ab= 0.22, 
SE: 0.19, 95% CI: -0.15, 0.59).  
 
5.5.3 Parental Depressive Symptoms 
Parental depressive symptoms were not assessed as a potential mediator using a GEE 
model as the results of the bivariate analysis revealed its lack of association with the 
outcome of interest. Evidence suggests that a potential mediator must be associated with 
the outcome to be eligible to mediate the relationship between an exposure and outcome 
(221–223). 
 
5.6 Objective 3 
5.6.1 Five-Year Seizure Freedom 
Similar to the second objective, a GEE model was used to assess the potential mediating 
effect of 5-year seizure freedom by 10 years post-diagnosis on the relationship between 
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early severity of epilepsy and subsequent youth depressive symptoms, adjusting for 
potential confounders (Table 5.9). The potential confounders were the same as those in 
the analyses to address the previous two objectives. The total effect of severity of 
epilepsy assessed in the first objective was 2.10 (95% CI: 0.42, 3.79 and the estimate of 
the direct effect when adding 5-year seizure freedom (M*) into the model decreased to -
0.89 (95% CI: -1.15, 2.92). The magnitude of the indirect effect was 1.22, which 
indicates that 5-year seizure freedom decreased the effect that severity of epilepsy had on 
the risk of depressive symptoms by approximately 58%. When testing the significance of 
the indirect effect, the GEE model indicated that 5-year seizure freedom mediated the 
relationship between early severity of epilepsy and subsequent youth depressive 
symptoms (ab= 1.22, SE: 0.44, 95% CI: 0.35, 2.09). Thus, the effect of early childhood 
severity of epilepsy was found to be of lesser importance when taking into account the 
more recent clinical presentation of the disease. Those who had not achieved 5-year 
seizure freedom were at greater risk of having depressive symptoms as compared to those 
who had achieved 5 years of seizure freedom by the 10-year follow-up. 
 
5.6.2 Antiepileptic Drug Use 
The potential mediating effect of AED use 10 years post-diagnosis on the relationship 
between early severity of epilepsy and subsequent youth depressive symptoms was 
assessed (Table 5.10). The total effect of severity of epilepsy assessed in the first 
objective was 2.10 (95% CI: 0.42, 3.79 and the estimate of the direct effect when adding 
AED use (M*) into the model decreased to 1.51 (95% CI: -0.51, 3.54). The magnitude of 
the indirect effect was 0.59, which indicates that AED use decreased the effect that 
severity of epilepsy had on the risk of depressive symptoms by 28%. However, when 
testing the significance of the indirect effect, the GEE model indicated AED use to not 
mediate the relationship between early severity of epilepsy and subsequent youth 
depressive symptoms (ab= 0.59, SE: 0.44, 95% CI: -0.27, 1.45). 
 
A final note is that without employing multiple imputation (Appendix F), the magnitude 
and direction of effects from the complete case analysis were similar to the findings 
presented here.  
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Table 5.1: Youth characteristics collected at the ten-year follow-up 
 
Youth Characteristics at 10 Years 
Age  mean (SD) 
range 
17.8 (2.6) 
12-23 
Age at Diagnosis mean (SD) 
range 
7.5 (2.4) 
3-12 
Sex  
Male 
Female 
n (%) 
 
 
63 (48.8) 
66 (51.2) 
Last Seizure 
<6 months ago 
>6 months ago to <1 year ago 
>1 year ago to <2 years ago 
>2 years ago to <5 years ago 
>5 years ago to <10 years ago 
10 years ago or more 
Does not recall 
n (%) 
 
 
 
12 (9.3) 
3 (2.3) 
7 (5.4) 
18 (14.0) 
57 (44.2) 
20 (15.5) 
11 (8.5) 
Current AED Use  
Yes 
No 
n (%) 
 
 
33 (25.6) 
93 (72.1) 
Last AED Used 
<6 months ago 
      >6 months ago to <1 year ago 
      >1 year ago to <2 years ago 
>2 years ago 
Has never taken medication for seizures 
Does not recall 
n (%) 
 
 
2 (2.2) 
0 (0) 
2 (2.2) 
61 (65.6) 
11 (11.8) 
14 (15.1) 
 
*For the ‘last seizure’ variable this table does not include imputed values from the parent-report for 
children who reported ‘do not recall’. 
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Table 5.2: Family characteristics at each of the six data collection points 
 
*Mean and standard deviation provided, unless otherwise stated.  
*Family Functioning (APGAR) scores range from 1 to 20. 
*Family Resources (FIRM) scores range from 16 to 72. 
*Parental Depressive Symptoms (CES-D) scores range from 0 to 40. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Family 
Characteristics 
Baseline 6 Months 1 Year 2 Years 8 Years 10 
Years 
Income  n(%) 
<$20,000 
$20,000-$39,999 
$40,000-$59,999 
$60,000-$79,999 
$80,000-$99,999 
>$100,000  
Does not know 
 
6 (4.7) 
12 (9.3) 
24 (18.6) 
22 (17.1) 
22 (17.1) 
38 (29.5) 
1 (0.8) 
 
9 (7.0) 
14 (10.9) 
17 (13.2) 
18 (14.0) 
22 (17.1) 
42 (32.6) 
3 (2.3) 
 
6 (6.7) 
17 (13.2) 
16 (12.4) 
17 (13.2) 
24 (18.6) 
43 (33.3) 
4 (3.1) 
 
6 (4.7) 
14 (10.9) 
21 (16.3) 
23 (17.8) 
14 (10.9) 
45 (34.9) 
1 (0.8) 
 
4 (3.1) 
11 (8.6) 
11 (8.6) 
15 (11.6) 
17 (13.2) 
59 (45.7) 
6 (4.7) 
 
2 (1.6) 
13 (10.1) 
9 (7.0) 
15 (11.6) 
16 (12.4) 
61 (47.3) 
2 (1.6) 
Parental Living 
Arrangements  n(%) 
Yes 
No 
 
 
116 (89.9) 
13 (10.1) 
 
 
112 (86.8) 
16 (12.4) 
 
 
113 (87.6) 
16 (12.4) 
 
 
114 (88.4) 
15 (11.6) 
 
 
106 (82.2) 
18 (14.0) 
 
 
102 (79.1) 
17 (13.2) 
Family Functioning 
n= 
14.3 (3.9) 
129 
14.4 (3.7) 
128 
14.2 (4.0) 
129 
14.2 (3.8) 
128 
14.2 (3.7) 
124 
14.6 (4.0) 
119 
Family Resources 
n= 
52.8 (10.7) 
129 
52.4 (11.5) 
127 
52.2 (10.8) 
128 
50.9 (11.5) 
128 
51.2 (11.3) 
124 
51.7 (11.9) 
119 
Parental Depressive 
Symptoms  n(%) 
CES-D score >16  
CES-D score <16  
 
12.3 (9.5) 
36 (28.1) 
92 (71.9) 
 
10.0 (8.6) 
29 (22.8) 
98 (77.2) 
 
11.3 (8.4) 
35 (27.3) 
93 (72.7) 
 
11.5 (9.6) 
33 (25.6) 
96 (74.4) 
 
11.2 (9.4) 
34 (27.4) 
90 (72.6) 
 
10.0 (9.0) 
27 (22.7) 
92 (77.3) 
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Table 5.3: Youth characteristics at each of the six data collection points 
 
Characteristics  Baseline 6 Months 1 Year 2 Years 8 Years 10 Years 
Severity of Epilepsy        
mean (SD) 
n= 
 
2.5 (1.1) 
125 
 
1.9 (1.1) 
120 
 
1.9 (1.1) 
118 
 
1.7 (1.1) 
117 
 
1.8 (1.1) 
30 
 
1.8 (1.2) 
32 
Seizure Type  
Generalized 
Partial 
Undetermined 
 
53 (41.1) 
75 (58.1) 
1 (0.8) 
 
54 (41.9) 
69 (53.5) 
0 (0.0) 
 
51(39.5) 
68 (52.7) 
0 (0.0) 
 
46 (35.7) 
66 (51.2) 
0 (0.0) 
 
18 (14.0) 
9 (7.0) 
3 (2.3) 
 
20 (15.5) 
11 (8.5) 
1 (0.8) 
Cognitive Problems  
Yes 
No 
 
9 (7.0) 
120 (93.0) 
 
10 (7.8) 
113 (87.6) 
 
21 (16.3) 
96 (74.4) 
 
25 (19.4) 
92 (71.3) 
 
9 (7.0) 
20 (15.5) 
 
10 (7.8) 
22 (17.1) 
Behavioural Problems  
Yes 
No 
 
12 (9.3) 
116 (89.9) 
 
18 (14.0) 
104 (80.6) 
 
15 (11.6) 
103 (79.8) 
 
17 (13.2) 
101 (78.3) 
 
8 (6.2) 
22 (17.1) 
 
8 (6.2) 
24 (18.6) 
 
*Frequency (%) reported, unless otherwise stated. 
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Table 5.4: Sensitivity analysis comparing baseline characteristics of youth retained for the 
ten-year follow-up and those who did not participate 
 
Variable 
 
Did Not 
Participate 
(n=242) 
Completed       
Follow-Up  
(n=131) 
p-value 
 
Sex 
Male 
Female 
 
132 (55%) 
110 (45%) 
 
63 (48%) 
68 (52%) 
0.23 
Age at Diagnosis (mean) 7.27 7.53 0.30 
Seizure Type 
Generalized 
Partial 
Undetermined 
 
89 (37%) 
145 (60%) 
5 (2%) 
 
54 (41%) 
75 (57%) 
2 (2%) 
0.74 
Severity of Epilepsy (mean) 2.68 2.45 0.07 
Behavioural Problems 
Yes 
No 
 
44 (18%) 
195 (81%) 
 
12 (9%) 
118 (90%) 
0.02 
Cognitive Problems 
Yes 
No 
 
65 (27%) 
173 (71%) 
 
9 (7%) 
122 (93%) 
<0.0001 
Household Income 
<$50,000 
$50,000-$99,999 
>$100,000 
 
89 (37%) 
93 (38%) 
42 (17%) 
 
32 (24%) 
56 (43%) 
38 (29%) 
0.008 
Parental Living Arrangements  
Living with spouse/partner 
Not living with spouse/partner 
 
205 (85%) 
37 (15%) 
 
118 (90%) 
13 (10%) 
0.15 
Family Functioning (mean) 13.68 14.32 0.12 
Family Resources (mean) 48.68 52.62 0.001 
Parental Depressive    
Symptoms (mean) 
15.35 12.33 0.007 
 
*Reported as frequencies, unless otherwise stated. 
*The p-value is from a chi-square or fisher’s exact test for categorical variables and t-test for continuous   
variables. 
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Table 5.5: Bivariate analysis with exposure, potential clinical and demographic 
confounders, and potential family and clinical mediators 
 
Variable Co-efficient (SE) 95% Confidence Interval 
Severity of Epilepsy 2.25 (0.82)** 0.63, 3.88 
Sex  
(ref=male) 
0.84 (1.80) -2.72, 4.40 
Age at Diagnosis 0.95 (0.37)* 0.22, 1.68 
Seizure Type      
(ref=generalized) 
1.67 (1.83) -1.94, 5.29 
Cognitive Problems 
(ref=yes) 
-1.86 (2.31) -6.44, 2.71 
Behavioural Problems     
(ref=yes) 
-2.64 (2.67) -7.93, 2.65 
Family Income 
(ref =<50,000) 
-0.90 (0.86) 
 
-2.60, 0.80 
 
Parental Living Arrangements 
(ref=yes) 
2.48 (2.56) -2.60, 7.56 
Family Functioning -0.60 (0.24)* -1.08, -0.11 
Family Resources -0.20 (0.08)* -0.36, -0.04 
Parental Depressive Symptoms 0.06 (0.10) -0.13, 0.25 
Five-Year Seizure Freedom 
(ref=yes)  
7.65 (1.76)*** 4.16, 11.14 
AED use 
(ref=yes)  
-5.56 (2.02)** -9.55, -1.56 
 
*p<0.02, **p<0.01, ***p<0.0001 
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Table 5.6: Multivariate regression analysis assessing the relationship between severity of 
epilepsy and depressive symptoms controlling for potential demographic and clinical 
confounders with multiple imputation (n=129) 
 
Variable Co-efficient (SE) 95% Confidence Interval 
Intercept 2.61 (8.76) -14.56, 19.78 
Severity of Epilepsy 2.10 (0.86)* 0.42, 3.79 
Sex 0.18 (1.82) -3.38, 3.74 
Age at Diagnosis 0.97 (0.38)* 0.23, 1.71 
Seizure Type 2.25 (1.81) -1.29, 5.79 
Cognitive Problems 0.69 (2.43) -4.07, 5.45 
Behavioural Problems -3.59 (2.80) -9.07, 1.89 
Family Income 0.08 (1.00) -1.88, 2.04 
Parental Living Arrangements 0.54 (2.82) -4.99, 6.07 
 
Note: The mean R2 across imputations was 12.5% (range: 12.1% to 13.0%). 
*p<0.02 
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Table 5.7: GEE model assessing family functioning as a mediator between the 
relationship of severity of epilepsy and depressive symptoms controlling for potential 
demographic and clinical confounders with multiple imputation (n=129) 
 
Variable Co-efficient (SE) 95% Confidence Interval 
Intercept 10.74 (9.23) -7.35, 28.82 
Severity of Epilepsy 1.86 (0.90)* 0.10, 3.61 
Sex -0.79 (1.78) -4.29, 2.70 
Age at Diagnosis 0.98 (0.35)** 0.30, 1.67 
Seizure Type 1.92 (1.67) -1.34, 5.19 
Cognitive Problems 0.74 (2.34) -3.85, 5.32 
Behavioural Problems -3.22 (3.11) -9.30, 2.87 
Family Income 0.36 (0.98) -1.56, 2.28 
Parental Living Arrangements -0.15 (2.76) -5.56, 5.27 
G -8.13 (4.65) -17.24, 0.98 
M* -0.46 (0.26) -0.97, 0.04 
G*Severity of Epilepsy 0.25 (0.17) -0.08, 0.57 
G*Sex 0.97 (0.56) -0.13, 2.07 
G*Age at Diagnosis -0.01 (0.05) -0.12, 0.09 
G*Seizure Type 0.33 (0.33) -0.32, 0.97 
G*Cognitive Problems -0.05 (0.40) -0.82, 0.73 
G*Behavioural Problems -0.38 (0.50) -1.35, 0.60 
G*Family Income -0.28 (0.21) -0.68, 0.13 
G*Parental Living Arrangements 0.69 (0.63) -0.54, 1.91 
 
*p<0.05, **p<0.01 
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Table 5.8: GEE model assessing family resources as a mediator between the relationship 
of severity of epilepsy and depressive symptoms controlling for potential demographic 
and clinical confounders with multiple imputation (n=129) 
 
Variable Co-efficient (SE) 95% Confidence Interval 
Intercept 10.00 (10.04) -9.68, 29.67 
Severity of Epilepsy 1.88 (0.89)* 0.13, 3.63 
Sex 0.08 (1.73) -3.31, 3.46 
Age at Diagnosis 0.88 (0.36)** 0.18, 1.59 
Seizure Type 2.03 (1.70) -1.29, 5.36 
Cognitive Problems 1.09 (2.38) -3.57, 5.75 
Behavioural Problems -3.59 (3.02) -9.52, 2.33 
Family Income 0.46 (1.02) -1.55, 2.46 
Parental Living Arrangements -0.44 (2.80) -5.94, 5.06 
G -7.39 (5.53) -18.23, 3.46 
M* -0.13 (0.09) -0.31, 0.06 
G*Severity of Epilepsy 0.22 (0.19) -0.15, 0.59 
G*Sex 0.10 (0.22) -0.33, 0.54 
G*Age at Diagnosis 0.09 (0.07) -0.06, 0.23 
G*Seizure Type 0.22 (0.28) -0.34, 0.77 
G*Cognitive Problems -0.40 (0.48) -1.33, 0.53 
G*Behavioural Problems 0.00 (0.30) -0.58, 0.58 
G*Family Income -0.37 (0.30) -0.97, 0.22 
G*Parental Living Arrangements 0.98 (0.82) -0.62, 2.58 
 
*p<0.05, **p<0.02 
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Table 5.9: GEE model assessing five-year seizure freedom as a mediator between the 
relationship of severity of epilepsy and depressive symptoms controlling for potential 
demographic and clinical confounders with multiple imputation (n=129) 
 
Variable Co-efficient (SE) 95% Confidence Interval 
Intercept -5.21 (7.99) -20.87, 10.45 
Severity of Epilepsy 0.89 (1.04) -1.15, 2.92 
Sex 0.45 (1.73) -2.94, 3.83 
Age at Diagnosis 0.90 (0.34)** 0.24, 1.56 
Seizure Type 2.21 (1.68) -1.07, 5.50 
Cognitive Problems -0.32 (2.47) -5.16, 4.53 
Behavioural Problems -1.66 (3.04) -7.62, 4.30 
Family Income 0.17 (0.94) -1.67, 2.01 
Parental Living Arrangements 0.55 (2.50) -4.35, 5.46 
G 7.82 (3.46)* 1.03, 14.61 
M* 5.91 (2.09)*** 1.82, 10.01 
G*Severity of Epilepsy 1.22 (0.44)** 0.35, 2.09 
G*Sex -0.27 (0.48) -1.20, 0.67 
G*Age at Diagnosis 0.07 (0.11) -0.13, 0.28 
G*Seizure Type 0.04 (0.46) -0.86, 0.94 
G*Cognitive Problems 1.01 (0.69) -0.35, 2.36 
G*Behavioural Problems -1.93 (1.04) -3.97, 0.10 
G*Family Income -0.09 (0.25) -0.58, 0.41 
G*Parental Living Arrangements -0.01 (0.74) -1.47, 1.45 
 
*P>0.05, **p<0.01, ***p<0.005 
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Table 5.10: GEE model assessing AED use as a mediator between the relationship of 
severity of epilepsy and depressive symptoms controlling for potential demographic and 
clinical confounders with multiple imputation (n=129) 
 
Variable Co-efficient (SE) 95% Confidence Interval 
Intercept 10.14 (10.93) -11.30, 31.57 
Severity of Epilepsy 1.51 (1.03) -0.51, 3.54 
Sex -0.01 (1.76) -3.45, 3.44 
Age at Diagnosis 0.87 (0.36)* 0.17, 1.57 
Seizure Type 2.67 (1.63) -0.53, 5.87 
Cognitive Problems 0.02 (2.44) -4.77, 4.81 
Behavioural Problems -2.76 (2.97) -8.57, 3.06 
Family Income -0.08 (0.96) -1.97, 1.82 
Parental Living Arrangements 0.26 (2.74) -5.11, 5.62 
G -7.53 (5.59) -18.48, 3.43 
M* -3.33 (2.43) -8.10, 1.44 
G*Severity of Epilepsy 0.59 (0.44) -0.27, 1.45 
G*Sex 0.19 (0.29) -0.38, 0.75 
G*Age at Diagnosis 0.10 (0.09) -0.08, 0.28 
G*Seizure Type -0.42 (0.38) -1.18, 0.33 
G*Cognitive Problems 0.67 (0.59) -0.49, 1.83 
G*Behavioural Problems -0.84 (0.76) -2.33, 0.66 
G*Family Income 0.16 (0.18) -0.20, 0.52 
G*Parental Living Arrangements 0.28 (0.40) -0.50, 1.07 
 
*p<0.02 
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Chapter 6 
6 Discussion 
This chapter begins with a summary and interpretation of the study results (Section 6.1). 
Next, the strengths and limitations of our study will be presented (Sections 6.2-6.3) 
followed by recommendations for future research and the implications of our study 
(Sections 6.4-6.5).  
 
6.1 Summary of Results 
This thesis aimed to assess the association between early severity of epilepsy and 
subsequent depressive symptoms in youth diagnosed with epilepsy during their 
childhood. With the stress process model as the guiding conceptual framework, family 
factors were examined as potential mediators of this relationship. Given the lengthy time 
period between the exposure and outcome, current clinical characteristics were also 
examined as potential mediators of the relationship between severity of epilepsy and 
youth depressive symptoms. To our knowledge, our study is the first to assess the nature 
of the relationship between early severity of epilepsy in childhood and depressive 
symptoms during adolescence and young adulthood.  
 
6.1.1 Relationship Between Severity of Epilepsy and Depressive Symptoms 
The first objective of this thesis was to assess the association between severity of epilepsy 
early in the course of the disease and subsequent depressive symptoms. Childhood 
epilepsy was presumed to have a lasting impression on children’s psychiatric health 
during their adolescent and young adulthood years due to its impact on their psychosocial 
development. Indeed, this study found early severity of epilepsy to be significantly 
associated with subsequent youth depressive symptoms. The more severe childhood 
epilepsy youth had, the greater their risk was for depressive symptoms as adolescents and 
young adults. This finding is of clinical importance for neurologists as they routinely 
assess patients’ severity of epilepsy. In the early course of the disease, neurologists may 
be able to predict which children are at higher risk of acquiring depression later in their 
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life and as such may educate parents whose child has a history of severe epilepsy on how 
to effectively monitor them for symptoms of depression. They may also recommend 
parents to promote positive mental health, provide a nurturing social environment, and 
may refer patients to mental health professionals on a case-by-case basis.  
Although no other study has examined early disease severity in childhood 
epilepsy as a risk factor for future psychiatric illnesses, cross-sectional studies have found 
an association between severity of seizures or epilepsy and psychiatric disorders (78–81). 
Austin et al. (1996) examined illness severity, a measure based on seizure type, frequency 
of seizures, and the number of AEDS/presence of side effects, as a predictor of mother 
and teacher reported internalizing problems, which include behaviours such as 
withdrawal, depression, and somatic complaints. They found that youth in the highest 
severity of epilepsy group had significantly more internalizing problems, as reported by 
both mothers and teachers using the Child Behaviour Checklist, compared to youth in the 
lowest severity group. Using the same sample of youth with epilepsy, Haber et al. (2003) 
examined disease severity as a risk factor of both self concept, measured using the 
Children’s Self-Concept Scale and depression, measured using the CDI. They had similar 
findings, where severity of epilepsy was highly correlated with self-concept, and 
marginally (yet not significantly) correlated with youth depression symptoms. Their 
sample differed from ours in two ways: the mean age of diagnosis for their sample was 
slightly younger (4.9 years vs. 7.5 years) and patients who were not receiving treatment 
for a year prior to study entry were excluded which was not a requirement for our study 
sample. As such, they excluded patients with less severe epilepsy not requiring treatment, 
potentially decreasing the range of disease severity in their sample. Our studies also 
differed in the follow-up times used for assessing severity of epilepsy and depressive 
symptoms, as they assessed both concurrently four years after study entry; consequently, 
it is unknown when the onset of depression occurred relative to epilepsy diagnosis. We 
assessed severity of epilepsy 2 years after diagnosis and depressive symptoms 10 years 
after diagnosis, allowing a temporal order between exposure and outcome. As severity of 
epilepsy changes over time, it is likely to influence the risk of depressive symptoms 
differently depending on when it is measured and when depressive symptoms are 
measured. Similarly, Chew et al. (2017) found higher severity of epilepsy to be 
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associated with poorer self-esteem using the same measure for severity. The final study 
by Turky at el. (2008) examined severity of seizures as a risk factor for psychiatric 
disorders; despite their small sample size (n=56), they had findings consistent with our 
study. Their results showed that increased severity of seizures and epilepsy, measured 
using the Liverpool Seizure Severity Scale, was associated with the risk of parent-
reported depression and emotional problems in youth ages 5 to 17 with epilepsy.  
Near the time of seizure-onset, a highly predictive characteristic of severity of 
epilepsy, frequency of seizures, has been found to be associated with depression in 
adolescents (82,83). In the first study, children and adolescents ages 9 to 18 who had 
daily seizures in the early stages of their epilepsy were found to be at a higher risk of 
depression and anxiety as compared to those who only had one seizure or were seizure 
free (83). This study had a very small sample of 35 patients with an onset of epilepsy 
ranging from 1 to 15.5 years. Depression was assessed using the CDI and anxiety was 
assessed using the State Trait Anxiety Inventory. The second study with a larger sample 
(n=140) of adolescents ages 10 to 18 years found more frequent weekly or daily seizures 
at onset were associated with the risk of depression but not anxiety, measured using the 
HADS (82). A notable distinction between these two studies is that the average disease 
duration of the first study was larger at 5.6 (SD:3.9) years as compared to the latter study 
with an average disease duration of 3.6 (SD:2.2) years for children and 4.8 (SD:3.4) years 
for adolescents. Accordingly, patients in the last study may not have had anxiety due to 
their longer duration of disease providing them with a longer window of time to adapt. 
No other studies were found that examined characteristics of early childhood severity of 
epilepsy as risk factors for later depressive disorders, as such there are no studies with 
opposing findings.  
 
6.1.2 Family Factors as Mediators 
The second objective examined the potential mediating effects of family functioning, 
family resources, and parental depressive symptoms in the relationship between early 
severity of epilepsy and subsequent youth depressive symptoms. The rationale behind 
this objective was that in previous studies these family factors had been found to be 
associated with both the exposure and outcome. Clinical aspects of epilepsy, including a 
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longer disease duration and higher frequency of seizures, have been found to be 
associated with poorer family functioning and consequently, poor family functioning has 
been found to be associated with depression in children with epilepsy 
(80,121,140,149,154,168). Level of family resources were previously found to be 
associated with severity of epilepsy and the risk of depression and internalizing behavior 
problems in children with epilepsy (81,86,140,156). Parental depressive symptoms have 
been shown to be associated with both severity of epilepsy and youth behavioural 
problems including depressive disorders (172,185). Furthermore, these family factors 
were found to be mediators of other similar relationships. A study of children with 
chronic illnesses, including epilepsy, found the relationship between having a chronic 
childhood illness and symptoms of anxiety and depression to be mediated by changes in 
both family dysfunction and maternal symptoms of depression over time (224). Among 
children with epilepsy, family mastery, an aspect of family resources, was found to 
mediate the relationship between severity of epilepsy and self-esteem (81). To the best of 
our knowledge, this is the first study to examine family functioning, family resources, 
and parental depressive symptoms as mediators of the relationship between severity of 
epilepsy and depressive symptoms.  
 Contrary to expectation, the results of our study suggest that the relationship 
between early childhood severity of epilepsy and subsequent youth depressive symptoms 
was not mediated by family functioning, family resources, or parental depressive 
symptoms. There are a number of factors one might consider as potentially explaining 
these findings. First, the majority of the sample had very mild epilepsy and thus their 
epilepsy may not have created as much disruption in the family environment as more 
severe epilepsy might have. This is supported by a previous study where families with 
children who had uncontrolled epilepsy were at a higher risk of having a poor quality of 
life (150). The results of our study also showed that most families were functioning well 
overall and had an adequate amount of resources. Hence, there was minimal variability in 
the sample, with most of the children living in a thriving family environment. As such, 
we may have been underpowered to detect a mediating effect for the family factors due to 
this lack of variability. The attrition analysis also revealed that families with lower 
household incomes, fewer resources, and parental depressive symptoms were less likely 
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to participate in the 10-year follow-up of this study. It is possible that if we had more 
disadvantaged families participate, the family factors would have presented as mediators. 
Second, there is potential for age-effects as the role of family factors, the severity 
of epilepsy, and depressive symptoms may differ between adolescents and young adults. 
Young adults may have greater autonomy and be less likely to be influenced by their 
family environment, relative to adolescents. Emerging adulthood (usually ages 18 to 25) 
is a time where many individuals move out of their homes to either attend post-secondary 
institutions, begin employment, or to live with their romantic partner whereas others 
continue to reside with their parents but begin to make independent life decisions (225). 
Differences in the prognosis of epilepsy based on age of diagnosis may exist as a long-
term prospective study found children diagnosed between the ages of 5 and 9 to be at the 
highest risk of having intractable epilepsy (226). Lastly, there may also be age-related 
differences in the prevalence of depression (227). To explore the potential for age effects 
in our study, a post-hoc analysis was conducted performing a stratified analysis 
separating adolescents (ages 12 to 17 years) from young adults (ages 18 to 24 years). The 
results of the relationship between early severity of epilepsy and youth depressive 
symptoms was no longer significant for either of the age groups. Subsequently, given no 
total effect between severity of epilepsy and depressive symptoms, the family factors 
were not mediators of this relationship. This may have been attributed to the small sample 
sizes as there were only 62 adolescents and 67 young adults. Alternatively, age effects 
may truly not exist as the prevalence of young adults in Canada co-residing with their 
parents is increasing over time (228). Youth with chronic illnesses are especially likely to 
be dependent on their parents longer (229) and as such, are likely affected by their family 
environment similar to their adolescent counterparts. This was the case in our study 
where only 8% of our sample was not residing with a family member at the 10-year 
follow-up.  
Third, the effect of family factors may have differed depending on the sex of the 
primary caregiver who reported them. Psychiatric illness among mothers, but not fathers, 
has been found to increase the risk of psychiatric illnesses in children with epilepsy (136). 
Moreover, sex differences exist in the prevalence of depression in adults, with women 
more commonly presenting with depression (230,231). There may be dissimilarities in 
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how women and men react to their child’s disease severity as mothers and fathers have 
been found to have differing attitudes towards their child’s epilepsy (80). These 
differences in parenting attitudes may be attributed to one parent being the primary 
caregiver and having different experiences with the child by communicating with and 
watching over the child more often than the other parent. It is difficult to assess whether 
these sex-based differences exist when examining only primary caregivers due to the 
small number of male primary caregivers in Canada. To achieve a homogenous sample of 
primary caregivers and reduce the risk of sex-based differences, a post-hoc analysis was 
done removing the five participants whose primary caregiver was their father. The results 
of the analyses remained consistent for all objectives as those presented in this thesis. 
This may be attributed to the negligible influence having fathers in the sample may have 
had due to their small sample size. The small proportion of primary caregivers being 
fathers is consistent with the gender of primary caregivers of children with health 
problems in Canada where the majority are mothers (232). Additionally, although 
discrepancies between mother’s and father’s ratings of family functioning and family 
resources have been found (80) these discrepancies may be minimal when the fathers 
included are the primary caregivers and have similar experiences to the primary 
caregiving mothers.  
Finally, it is possible that the potential family mediators act in a causal chain to 
mediate the relationship between severity of epilepsy and depressive symptoms. 
Following the social interactional and ecological theoretical framework, family factors 
have been grouped into four clusters based on their degree of proximity to the child’s 
everyday experience: proximal, distal, contextual, and global (family socio-economic 
status) (233). Rodenburg et al. (2006) suggested that proximal family factors (the quality 
of the parent-child relationship and parenting) are the strongest predictors of child 
psychopathology and thus, mediate the effects of contextual (the quality of other family 
relationships) and distal factors (parental characteristics). They found the effects of both 
parental depression and family functioning on the risk of child internalizing problems to 
be mediated by parental rejection. In our study, parental depressive symptoms would 
qualify as a distal family factor and family functioning and family resources would be 
contextual factors. Hence, it is plausible that parental depressive symptoms may affect 
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family functioning or family resources, which in turn, may lead to youth depressive 
symptoms. This has been shown in a study where the effect of family functioning on the 
outcome of youth internalizing problems was mediated by parental depressive symptoms 
(234). Still, these relationships are complex with another study finding that family 
functioning mediated the relationship between parental depressive symptoms and child 
emotional well-being and family resources mediated the effect of family functioning in a 
multiple mediation pathway (170). Differences in how family factors interact may be 
attributed to the youth’s age; cultural differences in parenting styles, as some cultures 
exercise stricter parenting than others; or the severity of epilepsy with more severe 
epilepsies having a greater impact on the family.  
Given the increased recognition of the value that family-centered care (FCC) has 
in improving both family and child outcomes, there is a need to further examine the role 
of family environment in childhood epilepsy to identify suitable targets for interventions 
(235). According to the Maternal and Child Health Bureau, the following activities 
characterize FCC: acknowledging the family as the constant in a child’s life, building on 
family strengths, supporting the child in participating, honoring diversity, recognizing the 
importance of community-based services, promoting an individual and developmental 
approach, encouraging family-to family/peer support, developing family-centered 
policies and practices, and celebrating success. Family factors not explored in our study 
that may also be targeted within the FCC framework include increasing parents’ 
confidence in managing their child’s epilepsy and teaching parents how to provide 
emotional support for their child (236). Both these factors may be affected by the severity 
of epilepsy and have been previously found to decrease child behaviour problems over 
time qualifying them as potential mediators for future studies to examine (156).  
 
6.1.3 Current Clinical Factors as Mediators 
The third and final objective examined the potential mediating effects of five years of 
seizure freedom and AED use, a decade post-diagnosis, for the relationship between early 
severity of epilepsy and depressive symptoms. The rationale behind this objective was to 
determine whether early severity of epilepsy is a risk factor for future depressive 
symptoms or whether its effect is based on it being a predictor of future severity of 
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epilepsy. Past studies have shown that early disease severity may be a predictor for 
whether a child will ever reach remission (77,237). Children with controlled epilepsy in 
the early stages are also the ones who successfully discontinue AED use (74–76). 
 The results of our study found that five-year seizure freedom mediates the 
relationship between early severity of epilepsy and subsequent depressive symptoms, 
reducing the effect of severity of epilepsy by 58%. This finding indicates that most of the 
effect of early disease severity is through gaining five-year seizure freedom which in 
turn, is associated with the risk of depressive symptoms. Those who have been free of 
seizures for the past five years a decade post-diagnosis are at lower risk of having 
depressive symptoms compared to those who have experienced a seizure in the past five 
years. This may be due to the fact that youth who have been free of seizures for this long 
are no longer emotionally or socially affected by their epilepsy and thus are not at as high 
of a risk of depressive symptoms, as compared to youth with active epilepsy. This is 
supported by other studies, as one found PWE who have been in remission for greater 
than five years to have less subjective handicap on all aspects of their daily life including 
physical, social, emotional, and occupational (114). The authors suggest that this finding 
may be attributed to a situation whereby the increasing time of remission increases 
patients’ confidence that their epilepsy is resolved for good. Similarly, in another study, 
adults who experienced none or very few seizures in the past year reported lower illness 
intrusiveness in domains including relationship and personal development, intimacy, and 
instrumental life compared to those who had frequent seizures (113). 
Although five-year seizure freedom has not been examined as a mediator, the 
results of one study are consistent with our findings where not being free of seizures for 
the past five years was associated with the risk of reporting internalizing problems 
(mainly depression and anxiety) (111). This study had a larger sample size (n=277) with 
children diagnosed up to 11 years of age, and as such they had a younger age range at 
their 9-year follow-up (8 to 17 years). In their sample, 64% of youth were free of seizures 
by the 9-year follow-up and 31% were using AEDs, these proportions are similar to our 
sample where 65% of youth had 5-year seizure freedom and 26% were using AEDs at the 
10-year follow-up. Discordantly, in the same cohort of children, five-years of seizure 
freedom was not associated with children’s HRQoL, but psychiatric disorders were 
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associated with HRQoL (110). One reason presented by the authors for this lack of 
association was that they used a generic instrument to measure HRQoL that may not have 
been sensitive to changes in epilepsy. A multi-step mediation pathway may also exist 
where five-year seizure freedom predicts psychiatric disorders which in turn, predict 
HRQoL. A population-based Canadian study of non-institutionalized PWE (N=713) over 
the age of 15 (Mean: 45.4 years) with ‘active epilepsy’, defined as either using an AED 
or experiencing a seizure within the past five years, found five-year seizure freedom to be 
associated with decreased odds of depression (112). Another study had consistent 
findings where significantly fewer adults with one-year seizure freedom (4%) had 
depression compared to those with active epilepsy (17%) (115). Although this study was 
cross-sectional, it had a large sample size (n=1069) and measured depression using a 
diagnostic screening tool (HADS).  
AED use was the second potential clinical mediator examined and the results 
found that it was not a mediator of the relationship between early severity of epilepsy and 
depressive symptoms. Although AED use was not a mediator, it did reduce the effect of 
early severity of epilepsy rendering it a non-significant risk factor for subsequent 
depressive symptoms. This may be due to the fact that there was a large but not full 
overlap between the variables of AED use and five-year seizure freedom. The majority 
but not all of the youth who were no longer using AEDs were the ones who have been 
free of seizures for the past five years. A explanation for the non-significant mediating 
effect is that AEDs have been shown to have psychotropic effects with some reducing 
and others increasing symptoms of depression (238). Unfortunately, we were unable to 
account for AED types due to lack of information on which AEDs youth were prescribed. 
This information likely would not have been that valuable due to the small sample of 
youth who were using AEDs and the availability of several AEDs in Canada, with some 
youth using various combinations. There may have also been a difference in the risk of 
depression for youth on polytherapy treatment compared to those only using one AED 
but, due to the lack of information and the small sample size, this could not be explored.  
The findings of this study indicate that reaching five-years of seizure freedom 
after a few years of having active epilepsy should be of paramount importance for 
clinicians. Whether there is a difference between those who are in remission with 
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treatment and those who are in remission without treatment must be explored further due 
to the small number of youth in remission with treatment in our sample. Findings from a 
study of adults with childhood-onset epilepsy followed for over 30 years indicated that 
those in 5-year seizure remission without treatment were influenced less by their epilepsy 
as compared to both those not in remission and those in remission with treatment (239). 
This is consistent with the Antiepileptic Drug Withdrawal Study that included patients 
over the age of 15 who were free of seizures for the past two years randomized to either 
slow or no discontinuation of AEDs (240). They found individuals in remission with 
treatment had greater feelings of stigma, felt that epilepsy restricted their social activities, 
and believed it affected their work and employment opportunities. These findings may be 
attributed to the successful discontinuation of AEDs lowering stigma associated with 
having active epilepsy.  
 
6.2 Strengths 
The longitudinal prospective nature of this study allowed temporality between the 
exposure, mediators, and outcome; a practice ideal for mediation analysis. It was one of 
the first long-term follow-up studies that allowed for the examination of the occurrence 
of a psychiatric disorder nearly a decade after the diagnosis of epilepsy in children. This 
study included only new-onset cases of epilepsy so was an incident sample with a sample 
size comparable to that of other studies. Data were collected at multiple time points 
making recall bias highly unlikely. It is also one of only a few long-term studies to 
include family factors as reported by the most knowledgeable person in the household, 
the primary caregiver. The potential family mediators and the outcome of interest, youth 
depressive symptoms, were all measured using validated tools. The exposure of interest, 
severity of epilepsy, was physician reported using a validated measurement tool making it 
a standardized measure of disease severity for all participants. The cohort in this study 
was representative of the general population of youth with epilepsy as the majority of 
cases were not severe. Lastly, this study provided an opportunity to examine the clinical 
presentation of the disease in the early stages and its relationship to the presence of 
seizures in the future.  
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6.3 Limitations 
This study was limited by the fact that depression in the early stages of epilepsy was not 
measured so causality between severity of epilepsy and depressive symptoms cannot be 
inferred. Measures for depressive symptoms would not have been feasible to implement 
given the young age of the sample at the time of diagnosis and the self-administered 
format for questionnaire completion. According to the parents’ reports on their child’s 
psychiatric disorder history, diagnosis of depression, if applicable, occurred after the 
diagnosis of epilepsy for our entire sample. A screening tool was used to identify who 
may be at risk for depression rather than a diagnostic tool hence we cannot make 
inferences regarding who has a depressive disorder and who does not.  
Within the stress process model, we have specified the direction of the 
relationships between variables, it is however possible that the outcome may have 
affected the mediators. If youth depressive symptoms were chronic and were present for 
over two years, they may have affected family functioning, family resources, and parental 
depressive symptoms. Youth depressive symptoms may have also influenced whether 
youth achieved five-year seizure-freedom if they required AEDs to control their seizures 
and their psychiatric health affected their compliance to their medication.  
Although we had a range in severity of epilepsy, we did not have many youth who 
had very severe epilepsy and no one in our sample required surgery to control their 
seizures. This means we cannot claim our findings are generalizable to youth with 
intractable epilepsy. The loss of families who had lower household incomes, fewer family 
resources, and were more likely to have parental depressive symptoms, produced a loss in 
the variability of family environment. With the loss of families who would be most at risk 
for negative outcomes, we were less likely to find significant effects for family factors. 
Accordingly, our findings may not be generalizable to low socio-economic status areas or 
disadvantaged populations. Our sample size, although one of the largest for a long-term 
follow-up study in childhood epilepsy, may have been underpowered to detect significant 
results in some of our analyses.  
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6.4 Recommendations for Future Research  
Future studies are warranted to explore the complexity of the relationship between 
epilepsy-related clinical factors, family environment, and youth depressive disorders 
given the importance of family in childhood epilepsy. These studies may examine 
different family factors, the roles of family factors in multiple mediator models and the 
potential moderating effects of family factors. Following family environment as children 
age, peer social support becomes important and may be a factor to examine as a potential 
mediator between severity of epilepsy and mental health outcomes. In a previous study, it 
was found to mediate the relationship between disease severity and family mastery (241). 
Studies with larger samples may examine the effects of age by stratifying by adolescent 
and adult ages given relatively different stressors between these age groups. Future 
studies should repeat a similar study with different psychiatric disorders as they are very 
common in youth with epilepsy such as anxiety or suicide. Future studies should also 
repeat a similar study in a more severe population of youth with epilepsy or those in 
disadvantaged areas.  
 
6.5 Implications and Conclusions 
The findings from this study suggest that early severity of epilepsy in childhood may be 
associated with depressive symptoms years later during adolescence and young 
adulthood. Health care professionals may consider educating parents on the high 
prevalence of depression in youth with epilepsy and offer resources on how depressive 
symptoms may present to aid parents in recognizing depression if it occurs. Physicians 
may also consider routinely screening for depression during examinations. A screening 
tool called the Neurological Disorders Depression Inventory for Epilepsy is a validated 
epilepsy population specific tool that can rapidly detect depression in clinics and is not 
resource intensive (37). Although our study did not find family factors to play mediating 
roles in the relationship between severity of epilepsy and depressive symptoms, this does 
not imply that they are not important. More research is required to uncover the roles of 
various family factors, their interrelations, and the usefulness of FCC in families of 
children with epilepsy. The finding that the influence of early severity of epilepsy is 
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mediated by seizure freedom for the past five years a decade after diagnosis of epilepsy 
indicates that children with severe childhood epilepsy are mostly at a high risk of 
depressive symptoms if they do not eventually gain control of their seizures. Having 
severe childhood epilepsy does not necessarily condemn children to have unfavourable 
psychiatric health in their adult years given there are opportunities to improve disease 
severity with surgery and other interventions if it does not resolve with AEDs.   
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APPENDIX A: PHYSICIAN FORM 
 
 
Patient’s Date of Birth (dd/mm/yy): __________    Site #:_____________ 
          
Please answer the following questions based on information from this patient’s most 
recent visit and return upon completion  
 
 
1. Date of patient’s last visit (dd/mm/yy): _______________  or Date of Telephone F/U 
(dd/mm/yy)____________ 
 
2. Date form completed (dd/mm/yy): _________________ 
 
 
 If information for 3 thru 7 is unchanged from baseline (diagnosis) visit, please check here 
and proceed to 8.   
 
                                                                                                                                                                                
3.   Seizure type(s):     1) ______________________             2)________________________ 
 
         3)______________________            4)________________________   
 
4.   Epilepsy syndrome:  _________________________ 
 
5.   Convulsive status epilepticus:    
  No   
  Yes 
 
6.   Exclusive nocturnal seizures:    
  No    
  Yes 
 
7. Age of first seizure (excluding febrile seizure): _______ yrs  
 
 
8.   Does this patient have any family with epilepsy?     
  No      
  Yes  
 
9.   Number of AEDs currently: ________ 
 
10. Number of AEDs total:  ________         
 
11. Is this patient of school age? 
  No 
  Yes → Grade: ___     regular class     regular class with resource     special class   
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12. Does the patient have behavioural problems?  
  No (normal) 
                  Yes →  Please check one:  mild       moderate      severe 
   
Diagnosis: _____________________ 
 
13. Does the patient have cognitive problems?   
  No (normal) 
    Yes → Please check one:  borderline      mild     moderate     severe 
 
       Diagnosis: ______________________ 
14.  Does this patient have motor problems? 
    No 
    Yes → Please check one:  mild     moderate   severe 
 
       Diagnosis: ______________________ 
 
15. Other neurological deficits? Please specify: ______________________________________ 
 
      ______________________________________ 
 
16.  Taking into account all aspects of this patient’s epilepsy, how would you rate its severity at  
 his/her last visit? Please check one answer. 
 
    Extremely severe 
    Very severe 
    Quite severe 
    Moderately severe 
    Somewhat severe 
    A little severe 
    Not at all severe      
 
17.   Rate the following aspects of this patient’s epilepsy at his/her last visit.  
 
Check one box using the following 7-point scale:  
1 = none or never 
7 = extremely frequent, severe or high 
 
 1 2 3 4 5 6 7 
Frequency of seizures        
Intensity of seizures        
Falls or injuries during seizures        
Severity of post-ictal period        
Amount of antiepileptic drugs        
Side effects of antiepileptic drugs        
Interference of epilepsy or drugs with daily activities        
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APPENDIX B: YOUTH SELF-REPORT MEASUREMENT TOOLS  
 
Center for Epidemiological Studies Depression Scale (CES-D) 
 
Please read these sentences that say something about how people sometimes feel and circle the number of 
the category on this page that best indicates how often you have felt this way in the past 7 days. 
 
 During the Past Week: 
Rarely or 
none of the 
time (less than 
1 day) 
Some or a 
little of the 
time  
(1-2 days) 
Occasionally 
or a moderate 
amount of 
time  
(3-4 days) 
Most or all of 
the time  
(5-7 days) 
a) I was bothered by things that 
usually don’t bother me.     
b) I did not feel like eating; my 
appetite was poor.     
c) I felt that I could not shake 
off the blues even with help 
from my family or friends. 
    
d) I felt that I was just as good 
as other people.     
e) I had trouble keeping my 
mind on what I was doing.     
f) I felt depressed.     
g) I felt that everything I did 
was an effort.     
h) I felt hopeful about the 
future.     
i) I thought my life had been a 
failure.     
j) I felt fearful.     
k) My sleep was restless.     
l) I was happy.     
m) I talked less than usual.     
n) I felt lonely.     
o) People were unfriendly.     
p) I enjoyed life.     
q) I had crying spells.     
r) I felt sad.     
s) I felt that people dislike me.     
t) I could not get “going”.     
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APPENDIX C: PARENT REPORT MEASUREMENT TOOLS  
 
Family Adaptability, Partnership, Growth, Affection Resolve (APGAR) 
 
Now we would ask that you think about the following and check the answer that best describes how you 
feel most of the time.  Please be honest. 
 
 
a) When something is bothering me, I can ask my family for help. 
 
        
              Never Hardly                Some of               Almost              Always 
                 the time                always 
 
 
b) I like the way my family talks things over and shares problems with me. 
 
      
  Never              Hardly               Some of                Almost              Always 
                            the time                 always 
 
c) I like how my family lets me try new things I want to do. 
 
      
 Never              Hardly               Some of                Almost              Always 
                            the time                 always 
 
d) I like what my family does when I feel mad, happy, or loving. 
 
      
 Never              Hardly               Some of               Almost              Always 
                            the time                always 
 
e)  I like how my family and I share time together. 
 
      
  Never              Hardly               Some of               Almost              Always 
                            the time                always 
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Family Inventory of Resources for Management (FIRM): Family Mastery and Health and Extended Family 
Social Support Subscales 
 
The next set of questions asks about what social, psychological, community and financial resources 
families believe they have available to them in the management of family life.  To complete this inventory 
you are asked to read the list of “Family Statements” one at a time.  In each statement, “family” means your 
immediate family (mother and/or father and children.)  Then ask yourself: “How well does the statement 
describe our family situation?” 
 
Then make your decision by circling one of the following: 
 
0 = Not At All This statement does not describe our family situation. This does not 
happen in our family. 
1 = Minimally This statement describes our family situation only slightly. Our family 
may be like this once in a while. 
2 = Moderately This statement describes our family situation fairly well. Our family is 
like this some of the time. 
3 = Very Well This statement describes our family very accurately. Our family is like 
this most of the time. 
 
Please read and record your decision for each of the statements below. 
 
 
 
 
 
Family Statements: N
ot 
at 
all
 
M
ini
ma
lly
 
M
od
er
ate
ly 
Ve
ry
 W
ell
 
a.  Being physically tired much of the time is a problem in our family 0 1 2 3 
b.  We have to nag each other to get things done 0 1 2 3 
c.  We do not plan too far ahead because many things turn out to be a matter 
of good or bad luck anyway 
0 1 2 3 
d.  Having only one person in the family earning money is (or would be) a 
problem in our family 
0 1 2 3 
e.  It seems that members of our family take each other for granted 0 1 2 3 
f.   Sometimes we feel we don’t have enough control over the direction our 
lives are taking 
0 1 2 3 
g.  Certain members of our family do all the giving, while others do all the 
taking 
0 1 2 3 
h.  We seem to put off making decisions 0 1 2 3 
i.   Our family is under a lot of emotional stress 0 1 2 3 
j.   Many things seem to interfere with family members being able to share 
concerns 
0 1 2 3 
k.  Most of the money decisions are made by only one person in our family 0 1 2 3 
l.   It seems that we have more illness (colds, flu, etc.) in our family than 
other people do 
0 1 2 3 
m. In our family some members have many responsibilities while others 
don’t have enough 
0 1 2 3 
n.  It is upsetting to our family when things don’t work out as planned 0 1 2 3 
o.  Being sad or “down” is a problem in our family 0 1 2 3 
p.  It is hard to get family members to cooperate with each other 0 1 2 3 
q.  Many times we feel we have little influence over the things that happen 
to us 
0 1 2 3 
r.   We have the same problems over and over – we don’t seem to learn from 
past mistakes 
0 1 2 3 
s.  There are things at home we need to do that we don’t seem to get done 0 1 2 3 
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Family Statements: N
ot 
at 
all
 
M
ini
ma
lly
 
M
od
er
ate
ly 
Ve
ry
 W
ell
 
t.   We seem to be so involved with work and/or school activities that we 
don’t spend enough time together as a family 
0 1 2 3 
u.  Our relatives seem to take from us, but give little in return 0 1 2 3 
v.   We try to keep in touch with our relatives as much as possible 0 1 2 3 
w.  Our relative(s) are willing to listen to your problems 0 1 2 3 
x.  Our relatives do and say things that make us feel appreciated 0 1 2 3 
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Center for Epidemiological Studies Depression Scale (CES-D) 
 
Now we’d like to ask some questions about you.  Please read these sentences that say something about how 
people sometimes feel and circle the number of the category on this page that best indicates how often you 
have felt this way in the past 7 days. 
 
 0.  Rarely or none of the time (less than one day) 
  1.  Some or a little of the time (1-2 days) 
 2.  Occasionally or a moderate amount of time (3-4 days) 
  3.  Most or all of the time (5-7 days) 
 
 
During the past seven days: 
 
a) I was bothered by things that usually don’t bother me.  0 1 2 3  
 
b) I did not feel like eating; my appetite was poor. 0 1 2 3 
 
c) I felt that I could not shake off the blues even with help from my  0 1 2 3 
 family or friends.  
 
d) I felt that I was just as good as other people. 0 1 2 3 
 
e) I had trouble keeping my mind on what I was doing. 0 1 2 3 
 
f) I felt depressed. 0 1 2 3 
 
g) I felt that everything I did was an effort. 0 1 2 3 
 
h) I felt hopeful about the future. 0 1 2 3 
 
i) I thought my life had been a failure. 0 1 2 3 
 
j) I felt fearful. 0 1 2 3 
 
k) My sleep was restless. 0 1 2 3 
 
l) I was happy. 0 1 2 3 
 
m) I talked less than usual. 0 1 2 3 
 
n) I felt lonely. 0 1 2 3 
 
o) People were unfriendly. 0 1 2 3 
 
p) I enjoyed life. 0 1 2 3 
 
q) I had crying spells. 0 1 2 3 
 
r) I felt sad. 0 1 2 3 
 
s) I felt that people dislike me. 0 1 2 3 
 
t) I could not get “going”. 0 1 2 3 
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APPENDIX E: PRELIMINARY CROSS-LAGGED PANEL AND REGRESSION 
ANALYSES 
 
In this study, the two-year follow-up was used for the exposure of interest (severity of epilepsy) and the 
eight-year follow-up was used for the potential family mediators. Thus, these time points were the main 
focus when determining the casual order between severity of epilepsy and the potential family mediators 
including family functioning, family resources and parental depressive symptoms. A cross-lagged panel 
analysis was conducted for each potential mediator in both the study sample (N=129) and the entire 
HERQULES project sample to compare results and whether associations changed when the sample size 
was much larger. Additionally, multiple linear regression analyses were conducted to further clarify the 
casual order between exposure and potential mediators.  
 
Table E-1: Cross-lagged panel analysis examining the relationship between family functioning (APGAR 
score) and severity of epilepsy (GASE score) for the study sample 
 
Variable Family 
Functioning 
Baseline 
Family 
Functioning 
6 Months 
Family 
Functioning 
1 Year 
Family 
Functioning 
2 Years 
Family 
Functioning 
8 Years 
Family 
Functioning 
10 Years 
Severity of 
Epilepsy    
10 Years 
r=-0.31 
p=0.08 
N=32 
r=-0.23 
p=0.22 
N=31 
r=-0.30 
p=0.10 
N=32 
r=-0.32 
p=0.07 
N=32 
r=-0.30 
p=0.11 
N=29 
r=-0.20 
p=0.29 
N=30 
Severity of 
Epilepsy  
8 Years 
r=0.13 
p=0.49 
N=30 
r=0.26 
p=0.18 
N=29 
r=-0.11 
p=0.55 
N=30 
r=0.04 
p=0.82 
N=30 
r=0.27 
p=0.14 
N=29 
r=0.24 
p=0.21 
N=28 
Severity of 
Epilepsy   
2 Years 
r=-0.16 
p=0.08 
N=117 
r=-0.09 
p=0.32 
N=116 
r=-0.14 
p=0.13 
N=117 
r=-0.17 
p=0.08 
N=116 
r=-0.28 
p=0.003 
N=112 
r=-0.21 
p=0.03 
N=108 
Severity of 
Epilepsy  
1 Year 
r=-0.20 
p=0.03 
N=118 
r=-0.24 
p=0.01 
N=117 
r=-0.21 
p=0.02 
N=118 
r=-0.19 
p=0.04 
N=117 
r=-0.21 
p=0.03 
N=113 
r=-0.18 
p=0.07 
N=110 
Severity of 
Epilepsy   
6 Months 
r=0.03 
p=0.72 
N=120 
r=-0.04 
p=0.65 
N=119 
r=-0.03 
p=0.77 
N=120 
r=0.01 
p=0.96 
N=119 
r=0.05 
p=0.57 
N=115 
r=0.06 
p=0.55 
N=110 
Severity of 
Epilepsy  
Baseline 
r=-0.12 
p=0.17 
N=125 
r=-0.03 
p=0.74 
N=124 
r=-0.07 
p=0.41 
N=125 
r=-0.05 
p=0.59 
N=124 
r=-0.07 
p=0.42 
N=120 
r=0.01 
p=0.91 
N=115 
                                          
The results (Table E-1) show that severity of epilepsy at two years is correlated with family functioning at 
eight years (p<0.005) but family functioning at two years and severity of epilepsy at eight years are not 
correlated with each other (p=0.82). Thus, early severity of epilepsy may be predictive of subsequent 
family functioning and not vice versa. However, this finding may have been attributed to the small sample 
size for severity of epilepsy at eight years. Thus, severity of epilepsy at two years and family functioning at 
earlier time points (baseline, six months, one year) were also examined and none of these relationships 
were significant further strengthening the hypothesis of the casual order of the relationship between 
severity of epilepsy and family functioning.  
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Table E-2: Cross-lagged panel analysis examining the relationship between family functioning (APGAR 
score) and severity of epilepsy (GASE score) for all participants in the HERQULES study 
 
Variable Family 
Functioning 
Baseline 
Family 
Functioning 
6 Months 
Family 
Functioning 
1 Year 
Family 
Functioning 
2 Years 
Family 
Functioning 
8 Years 
Family 
Functioning 
10 Years 
Severity of 
Epilepsy 
10 Years 
r=-0.17 
p=0.26 
N=45 
 
r=-0.16 
p=0.29 
N=44 
 
r=-0.22 
p=0.14 
N=45 
 
r=-0.35 
p=0.02 
N=45 
 
r=-0.32 
p=0.04 
N=40 
 
r=-0.27 
p=0.09 
N=39 
 
Severity of 
Epilepsy 
8 Years 
r=-0.06 
p=0.69 
N=48 
 
r=0.02 
p=0.89 
N=47 
 
r=-0.16 
p=0.29 
N=48 
 
r=-0.03 
p=0.83 
N=48 
 
r=0.11 
p=0.49 
N=46 
 
r=0.01 
p=0.94 
N=39 
 
Severity of 
Epilepsy 
2 Years 
r=-0.09 
p=0.11 
N=314 
 
r=-0.07 
p=0.25 
N=292 
 
r=-0.06 
p=0.30 
N=272 
 
r=-0.11 
p=0.07 
N=254 
 
r=-0.19 
p=0.01 
N=174 
 
r=-0.21 
p=0.007 
N=156 
 
Severity of 
Epilepsy 
1 Year 
r=-0.19 
p=0.0007 
N=329 
 
r=-0.14 
p=0.02 
N=306 
 
r=-0.13 
p=0.02 
N=280 
 
r=-0.17 
p=0.007 
N=261 
 
r=-0.13 
p=0.10 
N=178 
 
r=-0.19 
p=0.02 
N=160 
 
Severity of 
Epilepsy 
6 Months 
r=-0.03 
p=0.60 
N=335 
 
r=-0.05 
p=0.38 
N=306 
 
r=-0.08 
p=0.20 
N=281 
 
r=-0.09 
p=0.14 
N=261 
 
r=0.07 
p=0.35 
N=180 
 
r=0.03 
p=0.72 
N=161 
 
Severity of 
Epilepsy 
Baseline 
r=-0.10 
p=0.07 
N=362 
 
r=-0.05 
p=0.34 
N=327 
 
r=-0.07 
p=0.22 
N=294 
 
r=-0.10 
p=0.11 
N=273 
 
r=-0.04 
p=0.63 
N=186 
 
r=0.00 
p=0.97 
N=167 
 
 
The results were consistent when examining the entire HERQULES sample (Table E-3) as those found in 
the study sample (Table E-2).  
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Table E-3: Regression analysis to examine the association between severity of epilepsy at two years and 
family functioning at eight years controlling for baseline family functioning 
 
Variable Co-efficient (SD) p-value 
Intercept 7.90 (1.12) <0.0001 
2-Year Severity of Epilepsy   -0.52 (0.24) 0.03 
Baseline Family Functioning 0.52 (0.07) <0.0001 
 
A multiple linear regression analysis was conducted to further examine whether severity of epilepsy was 
associated with future family functioning when taking into account the baseline levels of family 
functioning. The results (Table E-3) found that severity of epilepsy at the two-year follow-up was 
associated with family functioning at the eight-year follow-up while controlling for family functioning at 
the time of epilepsy diagnosis (p<0.05). Thus, providing further support along with the cross-lagged panel 
analysis of the casual order of this relationship.  
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Table E-4: Cross-lagged panel analysis examining the relationship between family resources (FIRM score) 
and severity of epilepsy (GASE score) for the study sample 
 
Variable Family 
Resources 
Baseline 
Family 
Resources 
6 Months 
Family 
Resources 
1 Year 
Family 
Resources 
2 Years 
Family 
Resources 
8 Years 
Family 
Resources 
10 Years 
Severity of 
Epilepsy  
10 Years 
r=-0.37 
p=0.04 
N=32 
 
r=-0.32 
p=0.08 
N=31 
 
r=-0.39 
p=0.03 
N=32 
 
r=-0.25 
p=0.17 
N=32 
 
r=-0.47 
p=0.01 
N=29 
 
r=-0.43 
p=0.02 
N=30 
 
Severity of 
Epilepsy   
8 Years 
r=0.11 
p=0.5512 
N=30 
 
r=0.18 
p=0.36 
N=29 
 
r=0.01 
p=0.97 
N=30 
 
r=0.29 
p=0.12 
N=30 
 
r=0.01 
p=0.97 
N=29 
 
r=0.29 
p=0.13 
N=28 
 
Severity of 
Epilepsy   
2 Years 
r=-0.13 
p=0.16 
N=117 
 
r=-0.10 
p=0.30 
N=115 
 
r=-0.25 
p=0.006 
N=116 
 
r=-0.25 
p=0.007 
N=116 
 
r=-0.30 
p=0.001 
N=112 
 
r=-0.29 
p=0.003 
N=108 
 
Severity of 
Epilepsy   
1 Year 
r=-0.19 
p=0.04 
N=118 
 
r=-0.27 
p=0.004 
N=116 
 
r=-0.33 
p=0.0003 
N=117 
 
r=-0.21 
p=0.02 
N=117 
 
r=-0.20 
p=0.03 
N=113 
 
r=-0.27 
p=0.004 
N=110 
 
Severity of 
Epilepsy  
6 Months 
r=-0.06 
p=0.51 
N=120 
 
r=-0.12 
p=0.18 
N=118 
 
r=-0.17 
p=0.06 
N=119 
 
r=-0.04 
p=0.70 
N=119 
 
r=-0.01 
p=0.94 
N=115 
 
r=-0.08 
p=0.40 
N=110 
 
Severity of 
Epilepsy  
Baseline 
r=-0.09 
p=0.33 
N=125 
 
r=-0.09 
p=0.31 
N=123 
 
r=-0.13 
p=0.15 
N=124 
 
r=-0.10 
p=0.29 
N=124 
 
r=-0.09 
p=0.30 
N=120 
 
r=-0.10 
p=0.31 
N=115 
 
 
The results (Table E-4) show that severity of epilepsy at two years and family resources at eight years were 
significantly correlated (p=0.001) but severity of epilepsy at eight years was not correlated with family 
resources at two years (p=0.12). However, this finding may have been attributed to the small sample size 
for severity of epilepsy at eight years. Thus, severity of epilepsy at two years and family resources at earlier 
time points (baseline, six months, one year) were also examined. While baseline and six-month family 
resources were not significantly correlated with two-year severity of epilepsy, one-year family resources 
were significantly correlated with two-year severity of epilepsy (p<0.01). Since the correlation between 
severity of epilepsy at two years and family resources at eight years was stronger, the conclusion was that 
severity of epilepsy is more likely to precede family resources and thus family resources may be examined 
as a mediator in this study.  
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Table E-5: Cross-lagged panel analysis examining the relationship between family resources (FIRM score) 
and severity of epilepsy (GASE score) for all participants in the HERQULES study 
 
Variable Family 
Resources 
Baseline 
Family 
Resources 
6 Month 
Family 
Resources 
1 Year 
Family 
Resources 
2 Year 
Family 
Resources 
8 Year 
Family 
Resources 
10 Years 
Severity of 
Epilepsy  
10 Years 
r=-0.17 
p=0.25 
N=45 
 
r=-0.13 
p=0.42 
N=44 
 
 r=-0.18 
 p=0.24 
 N=44 
 
r=-0.18 
p=0.23 
N=45 
 
r=-0.40 
p=0.01 
N=40 
 
 r=-0.40 
p=0.01 
   N=39 
 
Severity of 
Epilepsy  
8 Years 
r=-0.05 
p=0.71 
N=48 
 
r=-0.01 
   p=0.94 
   N=47 
 
r=-0.06 
   p=0.67 
   N=48 
 
r=0.20 
p=0.18 
N=48 
 
r=0.06 
p=0.70 
N=46 
 
r=0.16 
   p=0.34 
   N=39 
 
Severity of 
Epilepsy   
2 Years 
r=-0.08 
p=0.18 
N=310 
 
r=-0.04 
p=0.48 
N=292 
 
r=-0.11 
p=0.08 
N=266 
 
r=-0.11 
p=0.08 
N=254 
 
r=-0.22 
p=0.004 
N=174 
 
 r=-0.24 
 p=0.002 
N=156 
 
Severity of 
Epilepsy   
1 Year 
r=-0.18 
p=0.001 
N=325 
 
r=-0.18 
p=0.001 
N=305 
 
r=-0.22 
p=0.0002 
N=275 
 
r=-0.19 
p=0.002 
N=260 
 
r=-0.14 
p=0.06 
N=177 
 
r=-0.19 
   p=0.01 
   N=160 
 
Severity of 
Epilepsy   
6 Months 
 r=-0.12 
 p=0.03 
 N=332 
 
r=-0.08 
p=0.16 
N=306 
 
  r=-0.11 
 p=0.08 
 N=276 
 
r=-0.10 
p=0.12 
N=261 
 
r=0.04 
p=0.61 
N=179 
 
 r=0.03 
 p=0.67 
 N=161 
 
Severity of 
Epilepsy  
Baseline 
r=-0.08 
p=0.15 
N=358 
 
r=-0.04 
p=0.51 
N=327 
 
r=-0.03 
p=0.63 
N=289 
 
r=-0.05 
p=0.46 
N=273 
 
r=-0.04 
p=0.63 
N=185 
 
r=0.01 
p=0.86 
N=167 
 
The results examining the entire HERQULES sample (Table E-5) provided further support for severity of 
epilepsy preceding family resources as severity of epilepsy at the two-year follow-up and family resources 
at the one-year follow-up were no longer significantly correlated as they were in the study sample (p=0.08). 
Similar to the findings in the study sample, two-year severity of epilepsy and eight-year family resources 
were significantly correlated (p<0.005) but two-year family resources and eight-year severity of epilepsy 
were not (p=0.18). 
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Table E-6: Regression analysis to examine the association between severity of epilepsy at two years and 
family resources at eight years controlling for baseline family resources 
 
Variable Co-efficient (SD) p-value 
Intercept 19.12 (4.00) <0.0001 
2-Year Severity of Epilepsy   -2.00 (0.66) 0.003 
Baseline Family Resources 0.68 (0.07) <0.0001 
 
A multiple linear regression analysis was conducted to further examine whether severity of epilepsy was 
associated with the future amount of family resources taking into account the baseline amount of family 
resources. The results (Table E-6) found that severity of epilepsy at the two-year follow-up was associated 
with family resources at the eight-year follow-up even while controlling for the amount of resources 
families had at the time of epilepsy diagnosis (p<0.005). Thus, providing further support along with the 
cross-lagged panel analysis of the casual order of this relationship.  
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Table E-7: Cross-lagged panel analysis examining the relationship between parental depressive symptoms 
(CES-D score) and severity of epilepsy (GASE score) for the study sample 
 
Variable Parental 
Depressive 
Symptoms 
Baseline 
Parental 
Depressive 
Symptoms  
6 Months 
Parental 
Depressive 
Symptoms  
1 Year 
Parental 
Depressive 
Symptoms  
2 Years 
Parental 
Depressive 
Symptoms  
8 Years 
Parental 
Depressive 
Symptoms 
10 Years 
Severity of 
Epilepsy  
10 Years 
r=0.24 
p=0.19 
N=32 
 
r=0.12 
p=0.53 
N=31 
 
r=0.20 
p=0.27 
N=32 
 
r=-0.03 
p=0.89 
N=32 
 
r=0.11 
p=0.57 
N=29 
 
r=0.25 
p=0.18 
N=30 
 
Severity of 
Epilepsy  
8 Years 
r=-0.11 
p=0.57 
N=30 
 
r=0.01 
p=0.97 
N=29 
 
r=0.03 
p=0.86 
N=30 
 
r=-0.16 
p=0.39 
N=30 
 
r=0.20 
p=0.29 
N=29 
 
r=-0.26 
p=0.17 
N=28 
 
Severity of 
Epilepsy   
2 Years 
r=0.14 
p=0.13 
N=116 
 
 r=0.23 
 p=0.01 
 N=115 
 
  r=0.24 
   p=0.009 
  N=116 
 
r=0.26 
 p=0.004 
N=117 
 
     r=0.25 
        p=0.009 
     N=112 
 
r=0.22 
p=0.02 
N=108 
 
Severity of 
Epilepsy   
1 Year 
r=0.17 
p=0.07 
N=117 
 
r=0.29 
p=0.002 
N=116 
 
r=0.29 
p=0.001 
N=117 
 
r=0.33 
 p=0.0002 
N=118 
 
r=0.13 
p=0.18 
N=113 
 
r=0.11 
p=0.24 
N=110 
 
Severity of 
Epilepsy   
6 Months 
   r=0.14 
   p=0.13 
   N=119 
 
r=0.19 
p=0.04 
N=118 
 
r=0.16 
p=0.09 
N=119 
 
r=0.06 
p=0.53 
N=120 
 
      r=0.00 
       p=1.00 
       N=115 
 
r=-0.04 
p=0.67 
N=110 
 
Severity of 
Epilepsy  
Baseline 
r=0.15 
p=0.09 
N=125 
 
r=0.08 
p=0.40 
N=123 
 
r=0.20 
p=0.03 
N=124 
 
r=0.15 
p=0.09 
N=125 
 
r=0.01 
p=0.92 
N=120 
 
r=-0.01 
p=0.91 
N=115 
 
 
Severity of epilepsy at two years and parental depressive symptoms at eight years were significantly 
correlated (p<0.01) but severity of epilepsy at eight years and parental depressive symptoms at two years 
were not correlated (p=0.4) (Table E-7). However, this finding may have been attributed to the small 
sample size for severity of epilepsy at eight years. Thus, severity of epilepsy at two years and parental 
depressive symptoms at earlier time points (baseline, six months, one year) were also examined. Although 
baseline parental depressive symptoms were not significantly associated with two-year severity of epilepsy, 
six-month (p<0.02) and one-year parental depressive symptoms (p<0.01) were significantly associated with 
two-year severity of epilepsy. Thus, it is possible that this relationship may be bidirectional.  
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Table E-8: Cross-lagged panel analysis examining the relationship between parental depressive symptoms 
(CES-D score) and severity of epilepsy (GASE score) for all participants in the HERQULES study 
 
Variable Parental 
Depressive 
Symptoms 
Baseline 
Parental 
Depressive 
Symptoms   
6 Months 
Parental 
Depressive 
Symptoms   
1 Year 
Parental 
Depressive 
Symptoms   
2 Years 
Parental 
Depressive 
Symptoms   
8 Years 
Parental 
Depressive 
Symptoms 
10 Years 
Severity of 
Epilepsy  
10 Years 
r=0.05 
p=0.72 
N=45 
 
r=0.10 
p=0.53 
N=44 
 
r=0.13 
p=0.41 
N=45 
 
r=0.06 
p=0.71 
N=44 
 
r=0.23 
p=0.15 
N=40 
 
r=0.28 
p=0.09 
N=39 
 
Severity of 
Epilepsy  
8 Years 
r=0.05 
p=0.74 
N=48 
 
r=0.28 
p=0.06 
N=47 
 
r=0.30 
p=0.04 
N=48 
 
r=-0.07 
p=0.64 
N=46 
 
r=0.17 
p=0.25 
N=46 
 
r=-0.03 
p=0.86 
N=39 
 
Severity of 
Epilepsy   
2 Years 
r=0.05 
p=0.40 
N=312 
 
r=0.16 
p=0.005 
N=292 
 
r=0.14 
p=0.03 
N=268 
 
r=0.17 
p=0.008 
N=253 
 
r=0.22 
p=0.003 
N=174 
 
r=0.20 
p=0.01 
N=155 
 
Severity of 
Epilepsy   
1 Year 
r=0.12 
p=0.03 
N=327 
 
r=0.16 
p=0.004 
N=305 
 
r=0.22 
p=0.0002 
N=277 
 
r=0.21 
p=0.0005 
N=260 
 
r=0.05 
p=0.48 
N=178 
 
r=0.07 
p=0.41 
N=159 
 
Severity of 
Epilepsy   
6 Months 
 r=0.08 
 p=0.14 
 N=333 
 
r=0.06 
p=0.32 
N=306 
 
r=0.12 
p=0.05 
N=278 
 
r=0.03 
p=0.61 
N=261 
 
r=-0.05 
p=0.53 
N=180 
 
r=-0.08 
p=0.34 
N=160 
 
Severity of 
Epilepsy  
Baseline 
r=0.08 
p=0.12 
N=361 
 
r=-0.01 
p=0.90 
N=327 
 
r=0.05 
p=0.42 
N=291 
 
r=0.11 
p=0.08 
N=272 
 
r=0.02 
p=0.74 
N=186 
 
r=-0.05 
p=0.55 
N=166 
 
 
The results examining the entire HERQULES sample were similar to those found in the study sample 
(Table E-8). However, the relationship between eight-year parental depressive symptoms and two-year 
severity of epilepsy was stronger than the relationship between six-month parental depressive symptoms 
and two-year severity of epilepsy, whereas in the study sample they were similar. Additionally, even with 
the larger sample the relationship between parental depressive symptoms at two years and severity of 
epilepsy at eight years was still not significant (p=0.64). Thus, it is more likely that parental depressive 
symptoms precede severity of epilepsy.   
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Table E-9: Regression analysis to examine the association between severity of epilepsy at two years and 
parental depressive symptoms at eight years controlling for baseline parental depressive symptoms 
 
Variable Co-efficient (SD) p-value 
Intercept 3.38 (1.55) 0.03 
2-Year Severity of Epilepsy    1.59 (0.66) 0.02 
Baseline Parental Depressive Symptoms 0.35 (0.07) <0.0001 
 
A multiple linear regression analysis was conducted to further examine whether severity of epilepsy was 
associated with future parental depressive symptoms taking into account the baseline parental depressive 
symptoms. The results (Table E-9) found that severity of epilepsy at the two-year follow-up was associated 
with parental depressive symptoms at the eight-year follow-up even while controlling for parental 
depressive symptoms at the time of epilepsy diagnosis (p<0.05). Thus, providing further support along with 
the cross-lagged panel analysis of the casual order between this relationship.  
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APPENDIX F: SENSITIVITY ANALYSIS  
 
Table F-1: Multivariate regression assessing the relationship between severity of epilepsy and depressive 
symptoms controlling for potential demographic and clinical confounders without multiple imputation 
(n=111) 
 
Variable Co-efficient (SE) 95% Confidence Interval 
Intercept 1.55 (8.98) -16.25, 19.36 
Severity of Epilepsy 2.19 (0.86)** 0.48, 3.91 
Sex 0.06 (1.88) -3.67, 3.80 
Age at Diagnosis 0.79 (0.40)* 0.00, 1.58 
Seizure Type 3.08 (1.93) -0.75, 6.92 
Cognitive Problems -0.07 (2.51) -5.05, 4.91 
Behavioural Problems -2.49 (2.97) -8.37, 3.40 
Family Income -0.29 (0.98) -2.24, 1.65 
Parental Living Arrangements 1.30 (2.81) -4.28, 6.87 
 
  Note: R2=13.8% 
  *p<0.05, **p<0.02 
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Table F-2: GEE model assessing family functioning as a mediator between the relationship of severity of 
epilepsy and depressive symptoms controlling for potential demographic and clinical confounders without 
multiple imputation (n=109) 
 
Variable Co-efficient (SE) 95% Confidence Interval 
Intercept 10.21 (9.45) -8.31, 28.73 
Severity of Epilepsy 1.85 (1.03) 0.17, 3.86 
Sex -1.11 (1.90) -4.83, 2.61 
Age at Diagnosis 0.80 (0.37)* 0.07, 1.53 
Seizure Type 2.73 (1.77) -0.73, 6.19 
Cognitive Problems 0.02 (2.53) -4.93, 4.97 
Behavioural Problems -1.95 (2.76) -7.37, 3.47 
Family Income 0.13 (0.97) -1.76, 2.03 
Parental Living Arrangements 0.57 (2.85) -5.01, 6.15 
G -8.62 (4.98) -18.38, 1.13 
M* -0.50 (0.28) -1.04, 0.04 
G*Severity of Epilepsy 0.30 (0.20) -0.09, 0.69 
G*Sex 1.09 (0.63) -0.14, 2.33 
G*Age at Diagnosis -0.04 (0.06) -0.16, 0.08 
G*Seizure Type 0.42 (0.39) -0.34, 1.19 
G*Cognitive Problems -0.06 (0.43) -0.91, 0.78 
G*Behavioural Problems -0.49 (0.52) -1.50, 0.52 
G*Family Income -0.36 (0.25) -0.85, 0.12 
G*Parental Living Arrangements 0.77 (0.66) -0.53, 2.07 
 
*p<0.05 
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Table F-3: GEE model assessing family resources as a mediator between the relationship of severity of 
epilepsy and depressive symptoms controlling for potential demographic and clinical confounders without 
multiple imputation (n=109) 
 
Variable Co-efficient (SE) 95% Confidence Interval 
Intercept 13.37 (9.83) -5.09, 32.64 
Severity of Epilepsy 1.78 (0.98) -0.15, 3.70 
Sex -0.25 (1.81) -3.80, 3.29 
Age at Diagnosis 0.61 (0.37) -0.12, 1.35 
Seizure Type 2.90 (1.79) -0.60, 6.40 
Cognitive Problems 0.70 (2.64) -4.47, 5.87 
Behavioural Problems -2.51 (2.73) -7.86, 2.83 
Family Income 0.38 (0.95) -1.50, 2.25 
Parental Living Arrangements -0.21 (2.88) -5.85, 5.43 
G -11.78 (5.45)* -22.46, -1.11 
M* -0.20 (0.09)* -0.38, -0.02 
G*Severity of Epilepsy 0.37 (0.23) -0.08, 0.82 
G*Sex 0.24 (0.37) -0.49, 0.96 
G*Age at Diagnosis 0.15 (0.09) -0.03, 0.32 
G*Seizure Type 0.25 (0.39) -0.50, 1.01 
G*Cognitive Problems -0.74 (0.70) -2.12, 0.64 
G*Behavioural Problems 0.08 (0.49) -0.88, 1.03 
G*Family Income -0.60 (0.33) -1.24, 0.04 
G*Parental Living Arrangements 1.55 (0.90) -0.22, 3.33 
 
*p<0.05 
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Table F-4: GEE model assessing five-year seizure freedom as a mediator between the relationship of 
severity of epilepsy and depressive symptoms controlling for potential demographic and clinical 
confounders without multiple imputation (n=110) 
 
Variable Co-efficient (SE) 95% Confidence Interval 
Intercept -2.83 (7.82) -18.15, 12.49 
Severity of Epilepsy 0.84 (1.07) -1.26, 2.94 
Sex 0.67 (1.82) -2.90, 4.25 
Age at Diagnosis 0.73 (0.33)* 0.09, 1.38 
Seizure Type 2.87 (1.74) -0.54, 6.29 
Cognitive Problems -1.33 (2.62) -6.46, 3.80 
Behavioural Problems -1.90 (2.87) -7.53, 3.73 
Family Income -0.27 (0.92) -2.07, 1.53 
Parental Living Arrangements 0.67 (2.47) -4.17, 5.51 
G 7.11 (3.43)* 0.38, 13.84 
M* 6.33 (2.18)** 2.06, 10.60 
G*Severity of Epilepsy 1.34 (0.47)** 0.42, 2.25 
G*Sex -0.37 (0.56) -1.46, 0.72 
G*Age at Diagnosis 0.04 (0.12) -0.19, 0.27 
G*Seizure Type -0.03 (0.55) -1.11, 1.05 
G*Cognitive Problems 0.94 (0.69) -0.42, 2.29 
G*Behavioural Problems -1.32 (0.95) -3.19, 0.55 
G*Family Income -0.07 (0.28) -0.62, 0.48 
G*Parental Living Arrangements 0.32 (0.82) -1.30, 1.94 
 
*p<0.05, **p<0.005 
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Table F-5: GEE model assessing AED use as a mediator between the relationship of severity of epilepsy 
and depressive symptoms controlling for potential demographic and clinical confounders without multiple 
imputation (n=109) 
 
Variable Co-efficient (SE) 95% Confidence Interval 
Intercept 8.81 (10.00) -10.79, 28.42 
Severity of Epilepsy 1.73 (1.10) 0.42, 3.88 
Sex -0.49 (1.82) -4.07, 3.08 
Age at Diagnosis 0.72 (0.37)* 0.00, 1.44 
Seizure Type 4.06 (1.74)** 0.66, 7.46 
Cognitive Problems -0.80 (2.66) -6.01, 4.42 
Behavioural Problems -1.90 (2.89) -7.55, 3.76 
Family Income -0.82 (0.95) -2.69,1.05 
Parental Living Arrangements 0.88 (2.82) -4.65, 6.42 
G -6.51 (5.89) -18.05, 5.04 
M* -2.79 (2.49) -7.67, 2.09 
G*Severity of Epilepsy 0.49 (0.44) -0.37, 1.35 
G*Sex 0.06 (0.23) -0.39, 0.51 
G*Age at Diagnosis 0.09 (0.10) -0.10, 0.28 
G*Seizure Type -0.33 (0.33) -0.97, 0.32 
G*Cognitive Problems 0.55 (0.56) -0.54, 1.64 
G*Behavioural Problems -0.68 (0.72) -2.09, 0.73 
G*Family Income 0.16 (0.18) -0.18, 0.51 
G*Parental Living Arrangements 0.36 (0.41) -0.45, 1.16 
 
*p<0.05, **p<0.02 
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